SPATIALIGHT INC
10KSB40, 1997-03-31
PHOTOGRAPHIC EQUIPMENT & SUPPLIES
Previous: PHYCOR INC/TN, 10-K, 1997-03-31
Next: AMERICAN DISPOSAL SERVICES INC, 10-K, 1997-03-31



<PAGE>

                         U.S. SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C. 20549
                                     FORM 10-KSB
                                           
[X] Annual report under Section 13 or 15(d) of the Securities Exchange
    Act of 1934 for the fiscal year ended December 31, 1996  or

[ ] Transition report under Section 13 or 15(d) of the Securities
    Exchange Act of 1934 for the transition period 
    from                to 
        -------------     --------------
COMMISSION FILE NUMBER:  000-19828

                                  SPATIALIGHT, INC.
                                  -----------------
                    (Name of Small Business Issuer in its Charter)
                                           
            NEW YORK                               16-1363082
            --------                               ----------
            (State or other jurisdiction           (I.R.S. Employer
            of incorporation or organization)      Identification No.)

                 8-C Commercial Blvd., Novato, California  94949-5759
                 ----------------------------------------------------
                       (Address of principal executive offices)
                                           
                                     415-883-1693
                                     ------------
                             (Issuer's telephone number)
                                           
              Securities registered under Section 12(b) of the Act: None
                                           
                Securities registered under Section 12(g) of the Act:
                                           
                             Common Stock $.01 par value
                             ---------------------------
                                   (Title of Class)
                                           
                                           
                                           
    Check whether the issuer (1) filed all reports required to be filed 
by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for 
such shorter period that the registrant was required to file such reports), 
and (2) has been subject to such filing requirements for the past 90 days: 
Yes [X] No [ ]

    Check if there is no disclosure of delinquent filers in response to Item 
405 of Regulation S-B contained in this form, and no disclosure will be 
contained, to the best of registrant's knowledge, in definitive proxy or 
information statements incorporated by reference in Part III of this Form 
10-KSB or any amendment to this Form 10-KSB.    [X]

    Issuer's revenues for the year ended December 31, 1996 aggregated $176,100.

    The aggregate market value for the Issuer's voting stock held by 
non-affiliates of the Issuer based upon the $1.0938  per share closing sale 
price of the Common Stock on March 21, 1997 as reported on the NASDAQ 
SmallCap Market, was approximately $4,354,693.43.  Shares of Common Stock 
held by each officer and director and by each person who owns 5% or more of 
the outstanding Common Stock have been excluded in that such persons may be 
deemed to be affiliates.  This determination of affiliate status is not 
necessarily a conclusive determination for other purposes.

    As of March 5, 1997, Registrant had 8,533,191 shares of Common Stock 
outstanding.

                         DOCUMENTS INCORPORATED BY REFERENCE
                                           
    Parts of the Proxy Statement for registrant's Annual Meeting of 
Stockholders to be held May 23, 1997 are incorporated by reference to Part 
III of this Form 10-KSB report.

    Transitional Small Business Disclosure Format (check one):

                      Yes                No   X
                         --------          --------


<PAGE>
                                  SPATIALIGHT, INC.
                             FORM 10-K SB  ANNUAL REPORT
                                           
                                  TABLE OF CONTENTS
                                           
                                                                        Page
                                        PART I
                                           
    ITEM 1    Description of Business                                     3

    ITEM 2    Description of Property                                     8

    ITEM 3    Legal Proceedings                                           8

    ITEM 4    Submission of Matters to a Vote
              of Security Holders                                         9


                                       PART II
                                           
    ITEM 5    Market for Common Equity and
              Related Stockholder Matters                                 9

    ITEM 6    Management's Discussion and Analysis
              or Plan of Operation                                        10

    ITEM 7    Financial Statements                                        14

    ITEM 8    Changes in and Disagreements with Accountants
              on Accounting and Financial Disclosure                      27


                                       PART III
                                           
    ITEM 9    Directors, Executive Officers, Promoters and
              Control Persons; Compliance with Section 16(a)
              of the Exchange Act                                         27

    ITEM 10   Executive Compensation                                      27

    ITEM 11   Security Ownership of Certain Beneficial
              Owners and Management                                       27

    ITEM 12   Certain Relationships and Related
              Transactions                                                27

    ITEM 13   Exhibits and Reports on Form 8-K                            28


                                         2
<PAGE>

ITEM 1.  DESCRIPTION OF BUSINESS

INTRODUCTION

    Spatialight, Inc. ("Spatialight" or the "Company") is in the business of 
designing, producing and commercializing miniature, high-resolution active 
matrix liquid crystal displays ("LCDs"), also known as spatial light 
modulators ("SLMs") for computer and video display applications.  SLMs are 
designed in a manner that can potentially provide high quality images at a 
significant reduction in costs over other types of computer and video 
displays currently available in the market.  The SLMs are designed to be 
capable of handling computer and video output at very high speeds, clarity 
and contrast.  The Company's first SLM product is a .75" diagonal, 704 x 512 
pixel, two-dimensional array on 20 micron centers which is manufactured 
domestically in very limited quantities. To date, the Company has sold only 
small volumes of its first SLM product to customers involved in the research 
and development of applications for this technology, including computer 
monitors, head-mounted displays, optical computing and other projection 
applications. 

    The Company has identified a number of potential applications and markets 
for products based on its SLM technology, including light-weight computer 
projection systems, large computer monitors and head-mounted displays for use 
in defense and aerospace applications and for computer training and gaming 
devices.  In addition, the Company believes that its SLM products may have 
application in optical computing systems and in high-speed, large-capacity 
optical data storage systems and holographic imaging systems.

    The address and telephone number of the Company's principal executive 
offices are 8-C Commercial Boulevard, Novato, California  94949;  (415) 
883-1693.  The Company was organized under the laws of the State of New York 
in 1989 under the name of "Sayett Acquisition Company, Inc."; it subsequently 
changed its name to Sayett Group, Inc. and, in June 1996, changed its name 
again to Spatialight, Inc.  Spatialight, Inc. holds 80% of the outstanding 
stock of Spatialight of California.  Prior to 1996, Spatialight, Inc. 
operated subsidiaries that were in the businesses of manufacturing populated 
circuit boards and manufacturing LCD projection equipment.  Both of these 
businesses were sold in 1995 and are accounted for as discontinued 
operations.  See "Management's Discussion and Analysis" and Notes to 
Consolidated Financial Statements -- Note 5. Unless the context 
requires otherwise, all references herein to Spatialight or the Company refer 
collectively to Spatialight, Inc., Spatialight of California and their wholly 
owned subsidiaries.

TECHNOLOGY AND PRODUCTS UNDER DEVELOPMENT

    The Company's only currently available product is a .75" diagonal, 704 x 
512 pixel, two-dimensional array on 20 micron centers. This product is 
manufactured in very small quantities domestically.  The Company currently 
has under development a 1024 x 768 pixel SLM product, which it anticipates 
will be commercially available in limited quantities for evaluation and 
development uses in mid 1997.  The Company's SLMs are based on an advanced, 
proprietary technology for using liquid crystal directly over the surface of 
a silicon chip to convert reflected external light into high-resolution 
images.  

    The technology underlying the Company's SLM products relies on the 
manipulation of liquid crystal.  A liquid crystal display ("LCD") 
consists of liquid crystal material between two pieces of glass, and 
associated polarizers. Rotating the polarization of the molecules in the 
liquid crystal changes the liquid crystal medium from opaque to 
transparent and can thereby control the transmission of light.  The 
liquid crystal material has long tubular molecules with a natural twist.  
The molecules untwist in response to an applied electric field.  As the 
molecules untwist, light can pass through the liquid crystal and its 
glass encasement.  Commonly available projection panels generally use 
super-twisted nematic ("STN") LCDs.  Molecules in STN LCDs have a high 
degree of twist and are very 

                                         3
<PAGE>

responsive to an applied electric field.  The Company's SLMs are designed to 
use the STN molecules by encasing them directly at the surface of an 
integrated circuit on a silicon chip.  The chip generates the polarizing 
electric fields which can be controlled by and therefore display a signal 
from a computer, cable television, a video cassette recorder or other type of 
high information content source.  The chip has a substrate manufactured with 
complimentary metal oxide semiconductor .8 micron processes that enables 
high-speed processing of computer and video output with high contrast and 
resolution.  Display glass is applied to the surface of the silicon chip with 
a "spin on" technology to improve flatness.  Improved flatness should enhance 
display quality and increase display size capability by reducing defects that 
would otherwise be magnified, and help maintain light efficiency to reduce 
power use.

    The Company's SLMs are being designed to compete with other technologies 
that produce color LCDs.  Additive color techniques require each dot or 
picture element ("pixel") on the display screen to be divided into three 
sub-pixels.  A color filter is applied to each sub-pixel, causing each 
subpixel to transmit red, green or blue light.  The viewer's eye combines the 
colored light from the three sub-pixels to create the perception of the full 
spectrum of colors.  Additive technologies, also referred to as "color 
filtered" technologies, include both passive and active matrix approaches.  
To date, active matrix has been most commonly accomplished through the use of 
thin film transistor technology ("TFT"), in which a transistor is placed on 
the glass substrate at each sub-pixel location and is used to control that 
sub-pixel.  TFT displays are currently manufactured in commercial quantities by 
Japanese manufacturers and are relatively expensive.  Further, TFT technology 
relies on the display being relatively small, because manufacturing costs and 
the costs of applying the display increase dramatically with size.

    The Company believes that the technology underlying its SLM products may 
provide certain advantages over TFT or other display products or 
technologies.  The Company's 704 x 512 product offers gray scaling at 256 
levels per pixel.  The Company's SLMs are expected to ultimately cost less to 
manufacture than comparable TFT displays because of the fundamental chip 
technology and the placement of the pixel format directly onto a silicon 
wafer.  Further, Company testing indicates that its SLMs are capable of being 
approximately 100 times as light efficient as currently available TFT 
displays.  The Company's 1024 x 768 product under development has a 90% fill 
factor with 20 micron pixel pitch.

    Although the Company has demonstrated SLM devices based on its 
core technology, and recently entered into a contract to produce an 
engineering prototype of a consumer product for mass production, the 
Company has not yet produced any prototype SLM products with quality and 
resolution sufficient to satisfy commercial end-use applications.  Delays 
in development may result in the Company's introduction of its products 
later than anticipated, which may have an adverse effect on both the 
Company's financial and competitive position.  Moreover, there can be no 
assurance that the Company will ever be successful in developing or 
manufacturing a commercially viable SLM device or any of its proposed 
display products.  In addition, there is no assurance that an SLM device 
or any of the Company's display products will be technically or 
commercially successful or that the Company will be able to manufacture 
or obtain a supplier for adequate quantities of its SLM devices or any of 
its display products at commercially acceptable cost levels or on a 
timely basis.

    The electronic imaging display industry has undergone rapid and significant
technological change.  The Company expects the technology to continue to develop
rapidly, and the Company's success will depend significantly on its ability to
attain and maintain a 


                                         4
<PAGE>

competitive position. Rapid technological development may result in actual 
and proposed products or processes becoming obsolete before the Company 
recoups a significant portion of related research and development, 
acquisition and commercialization costs.  If the Company is successful in the 
development of a commercially viable SLM device, the Company's ability to 
compete will depend in part upon the consistency of product quality and 
delivery, as well as pricing, technical capability and servicing, in addition 
to factors within and outside its control, including the success and timing 
of product introductions by the Company and its competitors, product 
performance and price, product distribution and customer support.  There can 
be no assurance that the Company's competitors will not succeed in developing 
technologies and products that are equally or more effective than any which 
are being developed by the Company or that will render the Company's 
technology, SLM devices or display and other products obsolete and 
non-competitive.

    APPLICATIONS AND MARKETS

    The Company believes that current and future SLM products may be 
incorporated into a wide variety of monitors, projectors and other light 
engines.  The Company also believes that suppliers and manufacturers of 
display products may desire to license the Company's technology for use in 
such end products.  The Company does not plan, nor does it have the financial 
resources, to develop or market any end products itself.  Therefore, the 
Company will be completely dependent upon independent third parties for the 
development, manufacturing and marketing of such products.  No such products 
exist today, and the Company does not have commitments from any third party 
for such development, manufacturing or marketing.  There can be no assurance 
that any third party will develop or market a product incorporating the 
Company's SLM's. If not, there will be no market for the Company's SLM's.  
However, the Company has entered into a development project with Packard Bell 
Electronics with the goal of incorporating the Company's SLMs into Packard 
Bell's monitor products in the future.  The Company has also established 
informal arrangements with suppliers of light engine components, including 
lamps, screen materials and lenses.  The Company believes these relationships 
are important to its ability to succeed because they can enable the Company 
to demonstrate potential application solutions to customers.  The failure to 
establish relationships with suppliers of light engine components and other 
manufacturers could make it more difficult for the Company to gain market 
acceptance for its products.  To encourage manufacturers to design products 
that integrate the Company's SLMs, the Company intends to offer prototypes at 
low cost for evaluation and design into products.  However, because many 
manufacturers are unfamiliar with reflective technology displays, and because 
of their limited supply, the Company may experience difficulty in convincing 
manufacturers to use its SLMs.

MARKETING, SALES AND DISTRIBUTION

    The Company's SLMs are available directly from the Company or through the 
Company's principal distributor, Meadowlark Optics.  The Company has a 
non-exclusive distribution agreement with Meadowlark to market the Company's 
SLMs in low volumes primarily to large corporate research departments and 
university research labs.  Currently available SLMs, including necessary 
electronics, have a per unit retail list price of $20,000.

    The Company currently employs no full-time sales or marketing specialists. 
The Company intends to form alliances with corporate partners for the marketing
and distribution of certain of its anticipated display products.  There can be
no assurance that the Company will be successful in forming and maintaining such
alliances or that the Company's partners will devote 


                                         5
<PAGE>

adequate resources to successfully market and distribute these anticipated 
products.  There can be no assurance that the Company will be able to attract 
and retain qualified marketing and sales personnel, that the Company will be 
able to enter into satisfactory agreements with marketing partners, or that 
the Company or its marketing partners will be successful in gaining market 
acceptance for its anticipated products.

    MANUFACTURING AND SUPPLY

      The Company currently engages outside manufacturers to produce its SLM 
devices, and the Company has no experience manufacturing SLM devices or 
display products.  The Company's facility is designed principally for 
research and development and small-scale assembly and inventory storage. 
Final assembly and testing of the SLM product is conducted by Company 
personnel prior to shipment.  The Company has established supplier 
relationships with both a low volume and a high volume LCD filling processor. 
 The Company does not have a written contract with either such supplier, and 
accordingly, either of them may discontinue providing LCD components to the 
Company at any time.  Any such termination of supply could have a material 
adverse effect on the Company's ability to meet its commitments to customers 
while the Company identified and qualified a replacement supplier.  The 
Company is negotiating with several manufacturers for establishment of 
full-scale integrated manufacturing capacity for its SLM devices and has 
reached an agreement with one manufacturer for fabrication of silicon wafers. 
 However, no decision has been made by any such manufacturer to establish 
such a capability and there can be no assurance that any of them will do so.  
In the event any such manufacturer establishes a full-scale integrated 
manufacturing capability, the Company could become dependent on such 
manufacturer for the manufacture of SLM devices.  The termination or 
cancellation of the Company's agreement with the manufacturer could adversely 
affect the Company's ability to manufacture its products.  In such event, the 
Company could be required to establish an alternative manufacturing 
relationship or establish its own manufacturing capability.  There can be no 
assurance that the Company would be able to establish such a relationship on 
acceptable terms or develop its own manufacturing capability. In any event 
the time required to establish such a substitute relationship or capability 
could substantially delay the commercialization of the Company's SLM devices 
and display products, which, in turn, could have a substantial adverse impact 
on the Company's results of operations and financial condition.

COMPETITION

    The active matrix LCD market has been dominated by Japanese manufacturers 
such as Sharp, Hitachi, Seiko-Epson, Sanyo and Toshiba (in partnership with 
IBM).  These manufacturers, however, have concentrated on larger format, 
eight to ten inch displays used in portable computers.  Other companies such 
as Kopin Corporation, OIS Ovonics, Texas Instruments and Motif (a Motorola 
and InFocus Systems joint venture) have attempted to design and produce small 
format LCDs and SLMs with comparable functionality to that of the Company's 
SLMs.  No attempts at commercialization of the small format display devices 
have been successful to date.

    The electronic imaging display industry has been characterized by rapid 
and significant technological advances.  There can be no assurance that the 
Company's SLM devices and display products will be reflective of such 
advances or that the Company will have sufficient funds to invest in new 
technologies or products or processes.  A number of companies in the United 
States assemble workstation monitors using LCDs and cathode-ray tubes 
("CRTs") purchased from Japan.  A number of Japanese companies build monitors 
around their LCDs and CRTs.  


                                         6
<PAGE>

Korean companies are also entering the LCD and CRT monitor market. 
Development of improved high-definition LCDs and CRTs continues to receive 
significant attention by these and other companies.  Although the Company 
believes that its SLM products have the capability to improve LCD performance 
beyond that of commercially available LCD- and CRT-based display products, 
there is no assurance that manufacturers of LCDs or CRTs will not develop 
further improvements of LCD or CRT technology that would eliminate or 
diminish the Company's anticipated advantage.  In addition, numerous 
competitors have substantially greater financial, technical and other 
resources than the Company. The Company may face an aggressive, well financed 
competitive response that may include misappropriation of the Company's 
intellectual property or predatory pricing. 

PATENTS AND INTELLECTUAL PROPERTY

    The Company's ability to compete effectively with other companies will 
depend, in part, on the ability of the Company to maintain the proprietary 
nature of its technologies.  Although the Company has been awarded or has 
filed applications for several patents in the United States, there can be no 
assurance as to the degree of protection offered by these patents, or as to 
the likelihood that pending patents will be issued.  Furthermore, the Company 
has not yet applied for or obtained any foreign patents.  There can be no 
assurance that competitors, in both the United States and foreign countries, 
many of which have substantially greater resources and have made substantial 
investments in competing technologies, will not seek to apply for and obtain 
patents that will prevent, limit or interfere with the Company's ability to 
make and sell its products or intentionally infringe the Company's patents.  
The defense and prosecution of patent suits is both costly and 
time-consuming, even if the outcome is favorable to the Company.  This is 
particularly true in foreign countries.  In addition, there is an inherent 
unpredictability regarding obtaining and enforcing patents in foreign 
countries. An adverse outcome in the defense of a patent suit could subject 
the Company to significant liabilities to third parties, require disputed 
rights to be licensed from third parties, or require the Company to cease 
selling its products.  The Company also relies on unpatented proprietary 
technology and there can be no assurance that others may not independently 
develop the same or similar technology or otherwise obtain access to the 
Company's proprietary technology. To protect its rights in these areas, the 
Company requires all employees and most consultants, advisors and 
collaborators to enter into confidentiality agreements.  There can be no 
assurance, however, that these agreements will provide meaningful protection 
for the Company's trade secrets, know-how or other proprietary information in 
the event of any unauthorized use, misappropriation or disclosure of such 
trade secrets, know-how or other proprietary information.  To date, the 
Company has no experience in enforcing its confidentiality agreements.

RESEARCH AND DEVELOPMENT

    The Company incurred research and development expenses of approximately 
$265,000 in 1996 and $509,766 in 1995.  Research and development expenses 
represent costs incurred, primarily personnel related, for the design and 
development of new products and the redesign of existing products.  The 
Company believes that the development of new products will be required to 
allow it to compete effectively and to achieve future revenues.  The Company 
currently has 11 full time employees  whose duties include research and 
development.  The Company intends to continue its product enhancement and 
development programs, focusing on increasing the display size and finalizing 
field sequential color capabilities and liquid crystal filling manufacturing 
processes.  The 


                                         7
<PAGE>

Company believes that such enhancements and new products will be required to 
exploit future markets for large screen monitors, high definition television 
and head mount displays.

EMPLOYEES

    As of December 31, 1996, the Company had 11 full-time and 4 part-time 
employees.  Employment is divided amount two functional areas with 12 in
engineering and 3 in finance and administration.  Employees are not 
represented by any collective bargaining organizations.  The Company 
considers its relations with its employees to be good.

    The Company is dependent upon its key scientific and management 
personnel, including its Chief Executive Officer, William Hollis, and its 
Vice President, Dean Irwin.  The Company does not maintain key-man life 
insurance on Messrs. Hollis or Irwin.  In 1996, the Company entered into a 
three-year employment agreement with Mr. Hollis and a two-year employment 
agreement with Mr. Irwin. Both agreements are terminable by the 
Company for cause.  The loss of the services of one or more key individuals 
may have a material adverse impact on the Company.  The Company's success 
will also depend on its ability to attract and retain other highly qualified 
scientific, marketing, manufacturing and other key management personnel.  The 
Company faces competition for such personnel and there can be no assurance 
that the Company will be able to attract or retain such personnel.

ITEM 2.  DESCRIPTION OF PROPERTY

    The Company's headquarters are located at 8-C Commercial Drive, Novato, 
California.  Approximately 4,000 square feet of office space is leased 
through April 1997.  The Company anticipates that this lease will be extended 
for another 12 months.  The Company believes that its current facilities will 
be sufficient for its needs for at least the next year.

ITEM 3.  LEGAL PROCEEDINGS.

    By letter dated January 13, 1997, counsel for Jalcanto, Ltd. and 
Sabotini, Ltd. (the "Investors") notified the Company that these Investors 
were electing to rescind the Share Purchase Agreements dated July 10, 1996, 
as amended (the "Purchase Agreements"), under which the Investors purchased a 
total of 2,135,000 shares of common stock in the Company, and were demanding 
a refund by January 17, 1997 of the purchase price of such shares, or 
$1,783,125, plus interest. The alleged ground for rescission is the fact that 
the Company's registration statement on Form S-3 pertaining to the resale of 
such shares was not declared effective by the SEC on or before December 31, 
1996.  Subsequently, by letter dated February 3, 1997, counsel for the 
Investors notified the Company that Jalcanto, Ltd. had retracted its demand 
for rescission, with reservation of all rights. The letter reiterated the 
rescission demand on behalf of Sabotini, Ltd., and the request that the 
Company return $891,563.

    On February 5, 1997, the Company was served notice that it has been sued 
by each of the Investors in the Superior Court of the State of California for 
the County of Marin. Each Investor filed a complaint for breach of contract, 
specific performance and indemnification relating to the alleged failure to 
timely complete the contractually required registration statement. In 
addition, each complaint requests that the court issue a preliminary and 
permanent injunction against future issuances of shares of the Company's 
common stock or securities convertible into common stock without the 
Investor's consent. The complaint filed by Sabotini Ltd. also requests 
rescission and the return of 

                                         8
<PAGE>

the full purchase price of its shares (approximately $892,000).  On February 
26, 1997, a hearing was held with respect to Sabotini's application for a 
writ to attach the Company's funds in the amount of $920,000 to ensure 
enforceability of any eventual judgment in Sabotini's favor. By order dated 
February 28, 1997, the court denied the application for the writ without 
prejudice.  

    The Company intends to defend itself vigorously in both actions and 
believes that it is not probable that Sabotini will prevail in 
rescinding its Purchase Agreement. The Company may be required to expend 
substantial funds and management resources in connection with the defense and 
any settlement or judgment; accordingly, the ultimate resolution of this 
litigation may have a material adverse effect on the Company's business and 
financial condition taken as a whole.

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

    No matters were submitted to a vote of the security holders during the 
Company's fourth quarter.


                                       PART II
                                           


ITEM 5.  MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.

    The Common Stock of the Company has been traded in the over-the-counter 
market since the Company's initial public offering on February 5, 1992.  The 
Common Stock is listed on the NASDAQ SmallCap Market under the symbol "SLHT". 
To remain listed, the Company must maintain certain maintenance standards, 
including: two market makers; bid price of $1.00; public float of 100,000 
shares; the market value of public float of $250,000; total assets of 
$2,000,000; capital and surplus of $1,000,000. NASD has delivered notice to 
the Company that it is scheduled for potential delisting from the Nasdaq 
SmallCap Market because the Company does not meet the $2,000,000 minimum 
total asset requirement for continued listing. On February 27, 1997, a 
hearing was held before a panel authorized by the NASD to determine whether 
the Company should be delisted from the Nasdaq SmallCap Market. No 
determination of that panel has yet been rendered. The Company presented a 
plan for compliance to the panel, but there can be no assurance that the 
Company will not be delisted when the panel renders its decision. If the 
Company were delisted from the Nasdaq SmallCap Market, trading, if any, in 
the Company's Common Stock would thereafter be conducted in the over-the-
counter market in the so-called "pink sheets" or the NASD's "Electronic 
Bulletin Board". Consequently, the liquidity of the Company's securities 
could be impaired, not only in the numbers of securities which could be 
bought and sold, but also through delays in the timing of transactions, 
reduction in security analysts' and news media coverage of the Company, and 
lower prices for the Company's securities than might otherwise be obtained.

    The following table sets forth, for the calendar quarters indicated, the 
range of high and low quotations for the Common Stock, as reported by the 
National Association of Securities Dealers Automated Quotation System.

SLHT - COMMON STOCK                           1996                1995
                                       High Bid  Low Bid   High Bid  Low Bid
                                       --------  -------   --------  -------

First Quarter (January - March)          1 1/2     7/32     3 1/4     1 3/8
Second Quarter (April - June)            1 5/8     5/8      2         1 1/4
Third Quarter (July - September)         1 1/4    11/16     1 7/8     1 1/4
Fourth Quarter (October - December)        7/8    13/32     1         9/16

    For a recent reported quotation for the Company's Common Stock, see the 
cover page of this Form 10-KSB.  The quotations listed above reflect 
inter-dealer prices, without retail mark-up, mark-down or commission and may 
not represent actual transactions.

    As of  March 21, 1997, there were approximately 2,900 holders of record 
of the Common Shares of the Company.  The Common Stock represents the only 
class of securities outstanding as of this filing.

    To date, the Company has not paid a dividend on its Common Stock.  The 
payment of future dividends is subject to the Company's earnings and 
financial position and such other 

                                         9
<PAGE>

factors, including contractual restrictions, as the Board of Directors may 
deem relevant and it is unlikely that dividends will be paid in the 
foreseeable future.

     During 1996, the Company sold securities in private placement 
transactions as follows. On July 11, 1996 the Company sold 1,585,000 shares 
of its common stock at a price of $1.125 per share in cash, and concurrently 
issued warrants to purchase an additional 1,585,000 shares of the Company's 
common stock (the "Warrants"). The shares sold and the Warrants were acquired 
on identical terms and in identical amounts by Sabotini, Ltd. and Jalcanto, 
Ltd., each of which are Isle of Man corporations (the "Investors"). The 
Warrants are exercisable at any time prior to July 15, 2001, at an exercise 
price of $1.00 per share before July 15, 1997, $1.25 per share though July 
1999 and $1.50 per share thereafter. On November 11, 1996, the Investors 
approved certain amendments to the Company's covenants under their original 
share purchase agreements, and the Company agreed to reprice the July 11, 
1996 sale of common stock from $1.125 per share to $0.8352 per share. As 
a result, the Company issued an additional 550,000 shares of its common 
stock, evenly divided between the two Investors.

     No underwriter took part in the sale of stock to the Investors, and 
there were no underwriting discounts or commissions; however the Company paid 
certain finders fees in connection with the transaction. Net proceeds 
received by the Company relating to the placement were $1,525,237. In making 
this private placement of securities, the Company claimed the exemption from 
registration under Section 4(2) of the Securities Act of 1933, as amended, 
pertaining to transactions not involving a public offering. In claiming this 
exemption, the Company relied upon factual information provided in 
representations by each Investor concerning its financial position, 
sophistication and suitability as a participant in such an exempt transaction.

ITEM 6.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
         RESULTS OF OPERATIONS

    The statements in "Management's Discussion and Analysis of Financial 
Condition and Results of  Operations" that relate to future plans, events 
or performance are forward-looking statements which involve risks and 
uncertainties. Actual results, events or performance may differ 
materially from those anticipated in these forward-looking statements as 
a result of a variety of factors, including those discussed throughout 
"Item 1 - Description of Business" and elsewhere in this Annual Report on 
Form 10-KSB. Readers are cautioned not to place undue reliance on these 
forward-looking statements, which speak only as of the date hereof. The 
Company undertakes no obligation to publicly release the result of any 
revisions to these forward-looking statements that may be needed to 
reflect events or circumstances after the date hereof or to reflect the 
occurance of unanticipated events.

    NET SALES. The Company's net sales were $176,100 and $95,857 in 1996 
and 1995 respectively. These amounts are comprised of sales of a small 
number of units of the Company's initial SLM device. 

    OPERATING EXPENSES.  Operating expenses during 1996 and 1995 were 
$1,170,007 and $2,522,457, respectively.  The substantial decrease in 
operating expenses from 1995 to 1996 was principally due to the write off 
of goodwill in 1995. 

    Costs of sales represent product costs associated with the production of 
prototype SLMs.  Costs of sale were $141,290 and $32,786 in 1996 and 1995, 
respectively.  The increase was due to the higher volume of SLM sales and 
high costs associated with the production of prototype units during 1996.  

    Selling, general and administrative costs were $763,575and $503,940 in 
1996 and 1995, respectively.  The increase of 52% from 1995 levels reflects 
the Company's initial investment in marketing the SLMs as it continued the 
transition from research and development company to an operating company.  
Also as a result of this transition, research and development expenses in the 
year ended December 31, 1996 were $265,142, which represents a 48% decrease 
from research and development expenses of $509,766 in the year ended December 
31, 1996. 

    The 1995 goodwill write-off resulted from the impairment of goodwill 
associated with the purchase of a majority interest in Spatialight of 
California during the first quarter of 1995.  At the time of purchase, it was 
anticipated that the sales of SLMs from Spatialight of California would 
continue to increase during the remainder of 1995 as production processes and 
component specifications were finalized for commercialization.  While the 
sales performance of Spatialight of California showed substantial improvement 
during the second and third quarters of 1995, the Company was unable to 
continue selling its products to one of its major customers.  As a result, 
the sales performance of Spatialight of California declined to zero in the 
fourth quarter of 1995.  This decline, coupled with the sale of Sayett 
Technology, a subsidiary of the Company focused on manufacturing LCD 
projection equipment, and the resultant diminished prospects that vertical 
integration would be available for Spatialight of California within the group 
of companies controlled by the Company led the Company to conclude that such 
goodwill was substantially impaired.  


                                         10
<PAGE>

    OTHER INCOME (EXPENSES) Losses in investee companies was $424,714 in 
1995. The losses in 1995 resulted from the write-off of the Company's entire 
investment in InterVision Systems, Inc.  The Company purchased a 40% interest 
in InterVision, a producer of head-mounted displays utilizing a wearable 
computer, in 1994.  Due to losses incurred by InterVision through the period 
ended December 31, 1995, the Company's investment was totally impaired.  
Although InterVision continues to operate, funded principally by a government 
grant, the Company does not anticipate that its investment will be recovered.

    Interest income was $63,776 and $63,427 in 1996 and 1995, respectively. 
Interest income in 1996 was principally due to interest on the proceeds of a 
private placement of the Company's Common Stock in July 1996.
    
    Other expenses were $13,252 and $2,705 in 1996 and 1995, respectively.  
The increase from 1995 resulted principally from expenses incurred in moving 
the Company's headquarters to California.

    On December 29, 1995 the Company sold Sayett Technology, Inc. (STI), a 
wholly owned subsidiary, to former management members of the Company for 
$300,000 in the form of a note receivable. In 1996, the Company received 
$51,526 in cash and $15,069 in furniture and fixtures toward payment of this 
note receivable. In the third quarter of 1996 the Company wrote down the note 
by $121,702 based on their assessment of collectability. Based on events in 
the fourth quarter of 1996, the Company wrote off the remaining balance of 
$111,703. The total write-off of $233,405 has been shown as a bad debt 
write-off.

    LOSS FROM CONTINUING OPERATIONS.  Losses from continuing operations were 
$1,178,738 and $2,791,990 in 1996 and 1995, respectively.  The Company 
anticipates that losses from continuing operations will increase during 1997. 

    DISCONTINUED OPERATIONS.  Total losses from discontinued operations were 
$1,863,393 in 1995.  During 1995, the Company sold Surmotech, Inc., a wholly 
owned subsidiary which focused on manufacturing populated circuit boards, for 
$188,000 in cash.  During 1995, the Company also sold Sayett Technology, 
Inc., a wholly owned subsidiary which focused on developing and manufacturing 
electronic presentation systems, for a $300,000 note receivable. 

    The consistent, recurring losses sustained by both companies prompted the 
Company to make the sales.  The operating results of the two entities have 
been combined and reported as "losses from discontinued operations, net of 
income tax."  Net sales from the discontinued operations in the year ended 
December 31, 1995 were approximately $5,462,000.

LIQUIDITY AND CAPITAL RESOURCES

    As of December 31, 1996, the Company had $1,324,398 in cash and cash 
equivalents.  Accounts receivable at December 31, 1996 totaled $40,201 and 
represented primarily amounts due on SLMs shipped in the fourth quarter.  The 
Company's net working capital at December 31, 1996 was approximately 
$1,249,000.

    Net cash used by operating activities totaled $904,354 and $36,252 in 
1996 and 1995, respectively.  Net cash provided by investing and financing 
activities in 1996 was approximately $1,550,000, principally resulting from a 
private placement of the Company's Common Stock.  Net cash used by investing 
and financing activities in 1995 was approximately $423,000, 

                                         11
<PAGE>

principally resulting from capital expenditures and purchase of an equity 
investment in InterVision Systems, Inc.

    As of December 31, 1996, the Company had an accumulated deficit of 
$7,464,081.  The Company has realized significant losses in the past and 
expects that these losses will continue at least through 1997.  It is likely 
that the Company will have quarterly and annual losses in 1997 and beyond.  
The Company has generated limited revenues and no profits from operations.  
The development, commercialization and marketing of the Company's products 
will require substantial expenditures for the foreseeable future.  
Consequently, the Company may continue to operate at a loss for the 
foreseeable future and there can be no assurance that the Company's business 
will operate on a profitable basis.

    The Company is experiencing negative cash flow from operations resulting 
in the need to fund ongoing operations from financing activities.  The future 
existence and profitability of the Company is dependent upon its ability to 
obtain additional funds to finance operations and expand operations in an 
effort to achieve profitability from operations.  No assurance can be given 
that the Company's business will ultimately generate sufficient revenue to 
fund the Company's operations on a continuing basis. The matters discussed 
above, among others, may indicate that the Company will be unable to continue 
as a going concern for a reasonable period of time.

    Most of the Company's revenue to date has been derived from research and 
development contracts and limited sales of its SLM devices.  Although the 
Company has demonstrated SLM devices based on its core technology, the 
Company has not yet produced any prototype SLM products with quality and 
resolution sufficient to satisfy commercial end-use applications.  The 
Company recently entered into a contract to produce an engineering prototype 
of a consumer product for mass production.  However, further development and 
testing will be necessary before this product or the Company's other proposed 
products will be available for commercial end-use applications.  Delays in 
development may result in the Company's introduction of its products later 
than anticipated, which may have an adverse effect on both the Company's 
financial and competitive position.  Moreover, there can be no assurance that 
the Company will ever be successful in developing or manufacturing a 
commercially viable SLM device or any of its proposed display products.  In 
addition, there is no assurance that an SLM device or any of the Company's 
display products will be technically or commercially successful or that the 
Company will be able to manufacturer adequate quantities of its SLM devices 
or any of its display products at commercially acceptable cost levels or on a 
timely basis.

    By letter dated January 13, 1997, counsel for Jalcanto, Ltd. and Sabotini,
Ltd. (the "Investors") notified the Company that these Investors were electing
to rescind the Share Purchase Agreements dated July 10, 1996, as amended (the
"Purchase Agreements"), under which  on July 11, 1996 the Investors purchased a
total of 2,135,000 shares of common stock in the Company, and were demanding a
refund by January 17, 1997 of the purchase price of such shares, or $1,783,125,
plus interest.  The alleged ground for rescission is the fact that the Company's
registration statement on Form S-3 pertaining to the resale of such shares was
not declared effective by the SEC on or before December 31, 1996.  Subsequently,
by letter dated February 3, 1997, counsel for the Investors notified the Company
that Jalcanto, Ltd. had retracted 


                                         12
<PAGE>

its demand for rescission, with reservation of all rights. The letter 
reiterated the rescission demand on behalf of Sabotini, Ltd., and the request 
that the Company return $891,563.
    
    On February 5, 1997, the Company was served notice that it has been sued 
by each of the Investors in the Superior Court of the State of California for 
the County of Marin. Each Investor filed a complaint for breach of contract, 
specific performance and indemnification relating to the alleged failure to 
timely complete the contractually required registration statement. In 
addition, each complaint requests that the court issue a preliminary and 
permanent injunction against future issuances of shares of the Company's 
common stock or securities convertible into common stock without the 
Investor's consent. The complaint filed by Sabotini Ltd. also requests 
rescission and the return of the full purchase price of its shares 
(approximately $892,000).  On February 26, 1997, a hearing was held with 
respect to Sabotini's application for a writ to attach the Company's funds in 
the amount of $920,000 to ensure enforceability of any eventual judgment in 
Sabotini's favor. By order dated February 28, 1997, the court denied the 
application for the writ without prejudice. 

    The Company intends to defend itself vigorously in both actions and 
believes that it is not probable that Sabotini will prevail in 
rescinding its Purchase Agreement. The Company may be required to expend 
substantial funds and management resources in connection with the defense and 
any settlement or judgment; accordingly, the ultimate resolution of this 
litigation may have a material adverse effect on the Company's business and 
financial condition taken as a whole.   

                             13

<PAGE>

ITEM 7.  FINANCIAL STATEMENTS


INDEPENDENT AUDITORS' REPORT

To the Board of Directors and Stockholders of 
Spatialight, Inc. and Subsidiary:

We have audited the accompanying consolidated balance sheets of Spatialight, 
Inc. and subsidiary (the "Company") as of December 31, 1996 and 1995, and the 
related consolidated statements of operations, stockholders' equity, and cash 
flows for each of the years then ended.  These financial statements are the 
responsibility of the Company's management.  Our responsibility is to express 
an opinion on these financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing 
standards.  Those standards require that we plan and perform the audit to 
obtain reasonable assurance about whether the financial statements are free 
of material misstatement.  An audit includes examining, on a test basis, 
evidence supporting the amounts and disclosures in the financial statements.  
An audit also includes assessing the accounting principles used and 
significant estimates made by management, as well as evaluating the overall 
financial statement presentation.  We believe that our audits provide a 
reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all 
material respects, the financial position of Spatialight, Inc. and subsidiary 
as of December 31, 1996 and 1995, and the results of their operations and 
their cash flows for the years then ended in conformity with generally 
accepted accounting principles.

The accompanying consolidated financial statements have been prepared 
assuming that the Company will continue as a going concern.  As discussed in 
Note 2 to the consolidated financial statements, successful completion of the 
Company's development program and ultimately, the attainment of profitable 
operations, is dependent on future events including obtaining adequate 
financing to fulfill its development activities, successful launching of the 
commercial production and distribution of its products and achieving a level 
of sales adequate to support the Company's cost structure.  As discussed in 
Note 4, to the consolidated financial statements, the Company is the 
defendant in litigation brought by shareholders who purchased common stock in 
1996. As further discussed in Note 2 to the consolidated financial 
statements, the Company's recurring operating losses and its accumulated 
deficit raise substantial doubt about its ability to continue as a going 
concern. Management's plans concerning these matters are also described in 
Note 2.  The consolidated financial statements do not include any adjustments 
that might result from the outcome of these uncertainties.




Deloitte & Touche LLP
San Francisco, California
March 21, 1997 


                                      14
<PAGE>


SPATIALIGHT, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 1996 AND 1995
- --------------------------------------------------------------------------------

                                                         1996         1995
                                                     ------------  ------------
ASSETS

CURRENT ASSETS:
 Cash and cash equivalents                            $1,324,398   $   678,300
 Accounts receivable                                      40,021            --
 Note receivable, net                                         --        81,451
 Inventories                                              75,401            --
 Prepaid expenses and other                               11,911         5,804
                                                     ------------  ------------
    Total current assets                               1,451,731       765,555
                                                     ------------  ------------

Property and equipment, net                               68,817        51,795
Other assets                                              12,877            --
Note receivable - noncurrent                                  --       218,549

TOTAL ASSETS                                          $1,533,425    $1,035,899
                                                     ------------  ------------
                                                     ------------  ------------

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
 Accrued expenses and other current liabilities      $  108,581    $    52,108
 Accounts payable                                        94,554             --
                                                     ------------  ------------
    Total current liabilities                           203,135         52,108
                                                     ------------  ------------

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY:
 Common stock, $.01 par value:
  20,000,000 shares authorized; issued and 
  outstanding 8,533,191 shares in 1996 and 
  6,398,191 shares in 1995                               79,832         63,532

 Additional paid-in capital                           8,714,539      7,205,602
 Accumulated deficit                                 (7,464,081)    (6,285,343)
                                                     ------------  ------------
    Total stockholders' equity                        1,330,290        983,791
                                                     ------------  ------------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY           $1,533,425     $1,035,899
                                                     ------------  ------------
                                                     ------------  ------------


See notes to consolidated financial statements.

                                        15
<PAGE>


SPATIALIGHT, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS
YEARS ENDED DECEMBER 31, 1996 AND 1995
- --------------------------------------------------------------------------------

                                                        1996          1995
                                                    ------------  ------------

NET SALES                                            $  176,100     $   95,857

OPERATING EXPENSES:
 Cost of sales                                          141,290         32,786
 Selling, general and administrative expenses           763,575        503,940
 Research and development expenses                      265,142        509,766
 Goodwill write-off                                          --      1,475,965
                                                    -----------   -----------
    Total operating expenses                          1,170,007      2,522,457
                                                    -----------   -----------

OPERATING LOSS                                         (993,907)    (2,426,600)
                                                    -----------   -----------

OTHER (EXPENSE) INCOME:
 Interest income                                         63,776        63,427
 Other expenses                                         (13,252)       (2,705)
 Losses in investee companies                                --      (424,714)
 Write-down of note receivable                         (233,405)           --
                                                    -----------   -----------
    Total other expense                                (182,881)      (363,992)
                                                    -----------   -----------
LOSS FROM CONTINUING OPERATIONS BEFORE 
  INCOME TAXES                                       (1,176,788)   (2,790,592)

INCOME TAXES                                             (1,950)       (1,398)
                                                    -----------   -----------
LOSS FROM CONTINUING OPERATIONS                      (1,178,738)   (2,791,990)

DISCONTINUED OPERATIONS:
 Losses from operations of discontinued 
  subsidiaries, net of income taxes                          --    (1,796,757)
 Loss on disposal of discontinued subsidiaries, 
  net of income taxes                                        --       (66,636)
                                                    -----------   -----------
NET LOSS                                            $(1,178,738)  $(4,655,383)
                                                    -----------   -----------
NET LOSS PER SHARE:
 From continuing operations                         $     (0.16)   $    (0.44)
 From operations of discontinued subsidiaries                --         (0.28)
 From disposal of discontinued subsidiaries         $        --         (0.01)
                                                    -----------   -----------
NET LOSS PER SHARE                                  $     (0.16)   $    (0.73)
                                                    -----------   -----------
                                                    -----------   -----------
Shares used in computing net loss per share           7,230,630     6,312,283
                                                    -----------   -----------
                                                    -----------   -----------



See notes to consolidated financial statements.


                                        16

<PAGE>


SPATIALIGHT, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
YEARS ENDED DECEMBER 31, 1996 AND 1995
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
                                          COMMON STOCK           ADDITIONAL                     TOTAL
                                  ----------------------------    PAID-IN     ACCUMULATED   STOCKHOLDERS'
                                    SHARES          AMOUNT        CAPITAL      (DEFICIT)        EQUITY
                                  -----------     ------------  ------------  ------------- --------------
<S>                               <C>              <C>           <C>          <C>            <C>
Balance January 1, 1995            6,043,648        $ 59,986     $6,411,425    $(1,629,960)   $4,841,451

Issuance of common stock             354,543           3,546        794,177                      797,723

Net loss                                  --              --             --     (4,655,383)   (4,655,383)
                                  -----------     ------------  ------------  ------------- --------------
Balance December 31, 1995          6,398,191          63,532      7,205,602     (6,285,343)      983,791
                                  -----------     ------------  ------------  ------------- --------------
Issuance of common stock, net      2,135,000          16,300      1,508,937            --      1,525,237

Net loss                                 --              --             --      (1,178,738)   (1,178,738)
                                  -----------     ------------  ------------  ------------- --------------
Balance December 31, 1996         $8,533,191        $ 79,832     $8,714,539    $(7,464,081)   $1,330,290
                                  -----------     ------------  ------------  ------------- --------------
                                  -----------     ------------  ------------  ------------- --------------
</TABLE>


See notes to financial statements.


                                        17

<PAGE>


SPATIALIGHT, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31, 1996 AND 1995
- -------------------------------------------------------------------------------
  
                                                         1996         1995
                                                   -------------  -------------
OPERATING ACTIVITIES:
 Net loss                                           $(1,178,738)   $(4,655,383)
 Adjustments to reconcile net loss 
  to net cash used by operating activities:
  Depreciation and amortization                          24,358        357,690
  Losses in investee companies                               --        424,714
  Goodwill write-off                                         --      1,475,965
  Write-down of note receivable                         233,405             --
  Loss on disposal of discontinued subsidiaries              --        (41,791)
  Changes in assets and liabilities:
   Investments (trading securities)                          --        571,714
   Accounts receivable                                  (40,021)     1,012,020
   Inventories                                          (75,401)     1,481,842
   Other receivables                                         --        124,763
   Prepaid expenses and other current assets             (6,107)        89,001
   Other assets                                         (12,877)        65,072
   Accounts payable                                      94,554       (592,032)
   Accrued expenses and other current liabilities        56,473       (166,897)
   Product warranty                                          --       (182,930)
                                                   -------------  -------------
    Net cash used by operating activities              (904,354)       (36,252)
                                                   -------------  -------------
INVESTING ACTIVITIES:
 Purchase of short-term investments                  (1,172,900)
 Proceeds from sales of short-term investments        1,172,900
 Capital expenditures                                   (26,311)      (212,831)
 Purchase of equity investment                                --      (375,000)
 Payments received on notes receivable                   51,526             --
 Net proceeds from acquisitions/disposals                    --        164,352
                                                   -------------  -------------
    Net cash provided (used) by investing 
     activities                                          25,215       (423,479)
                                                   -------------  -------------
FINANCING ACTIVITIES:

 Proceeds from the sales of common stock, 
  net of issuance costs                              1,525,237              --
                                                   -------------  -------------
     Net cash provided by financing activities       1,525,237              --
                                                   -------------
NET (DECREASE) INCREASE IN CASH AND 
  CASH EQUIVALENTS                                     646,098        (459,731)

CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR           678,300       1,138,031
                                                   -------------  -------------
CASH AND CASH EQUIVALENTS, END OF YEAR              $1,324,398      $  678,300
                                                   -------------  -------------
                                                   -------------  -------------
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND
 FINANCING ACTIVITIES:
  Furniture received as payment on notes 
   receivable                                       $   15,069
                                                   -------------  
  Debentures in SOC converted to common 
   stock of SOC                                                     $  466,105
                                                                  -------------
  Common stock issued in conjunction with 
   acquisition of SOC                                               $  797,723
                                                                  -------------
See notes to consolidated financial statements.


                                        18

<PAGE>

SPATIALIGHT, INC. AND SUBSIDIARY
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED DECEMBER 31, 1996 AND 1995
- -------------------------------------------------------------------------------

1. DESCRIPTION OF BUSINESS 

   Spatialight, Inc. and its subsidiary (the Company) develops, designs, 
   manufactures, and markets high content information display system components 
   for the optical computing, computer monitoring/projection, holography, and 
   multimedia industries.
   
2. GOING CONCERN UNCERTAINTY
   
   The Company incurred significant operating losses in each of the last 
   five fiscal years and incurred a net loss in fiscal 1996 of $1,178,438.  
   Additionally, as of December 31, 1996 the Company's accumulated deficit 
   totaled $7,464,081.  The Company has generated limited revenues to date 
   and the development, commercialization and marketing of the Company's 
   products will require substantial expenditures in the foreseeable 
   future. The successful completion of the Company's development program 
   and ultimately, the attainment of profitable operations, is dependent 
   upon future events. These events include the obtaining adequate 
   financing to fulfill its development activities, successful launching of 
   the commercial production and distribution of its products and achieving 
   a level of sales adequate to support the Company's cost structure. The 
   accompanying consolidated financial statements have been prepared on a 
   going concern basis, which contemplates the realization of assets and 
   the satisfaction of liabilities in the normal course of business.  These 
   matters discussed above, among others, may indicate that the Company 
   will be unable to continue as a going concern for a reasonable period of 
   time. 
   
   The consolidated financial statements do not include any adjustments 
   relating to the recoverability and classification of recorded asset 
   amounts or the amounts and classification of liabilities that might be 
   necessary should the Company be unable to continue as a going concern.
   
   In an effort to improve operating performance, the Company has been and 
   will be implementing certain programs and strategies in 1997.  These 
   strategies include:
   
   - Raising of additional capital.

   - Outsourcing of all manufacturing activities, which will be monitored by 
     Company's manufacturing/quality control engineering staff. 

   - Developing strategic arrangements with potential customers to share 
     development costs and/or licensing of the Company's technology. 

   - Construction of engineering models to demonstrate proof of technology 
     for OEM's. 
   
   The Company's continuation as a going concern is dependent upon its 
   ability to generate sufficient cash flow to meet its obligations on a 
   timely basis, to obtain additional financing, and ultimately to attain 
   successful operations. Management is continuing its efforts to obtain 
   additional funds so that the Company can meet its obligations and 
   sustain its operations.
   
                                        19

<PAGE>

3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

   PRINCIPLES OF CONSOLIDATION - The consolidated financial statements 
   include the accounts of Spatialight, Inc. (SI), and its majority-owned 
   subsidiary Spatialight of California (SOC).  All inter-company accounts 
   and transactions have been eliminated in consolidation.  
   
   ESTIMATES - The preparation of consolidated financial statements in 
   conformity with generally accepted accounting principles requires that 
   management to make estimates and assumptions that affect the reported 
   amounts of assets and liabilities and disclosure of contingent assets 
   and liabilities at the date of the consolidated financial statements and 
   the reported amounts of revenues and expenses during the reporting 
   period.  Actual results could differ from those estimates.
   
   INVENTORIES - Inventories are stated at the lower of cost or market, 
   cost being determined on a first-in, first-out (FIFO) basis.
   
   PROPERTY AND EQUIPMENT - Property and equipment are recorded at cost 
   while repairs and maintenance costs are expensed in the period incurred. 
   Depreciation and amortization of property and equipment is calculated 
   on a straight-line basis over the estimated useful lives of the assets, 
   generally 3 to 5 years.
   
   REVENUE RECOGNITION - Revenue is generally recognized at the time 
   product is shipped.
   
   INCOME TAXES - The Company uses the asset and liability method to 
   account for income taxes, in accordance with Statement of Financial 
   Accounting Standards No. 109, "Accounting for Income Taxes." 

   NET LOSS PER COMMON SHARE - Net loss per common share for 1996 and 1995 
   is based on the weighted average number of common shares outstanding 
   during the year; stock options and warrants were not included since 
   their effect would be anti-dilutive. 
   
   RESEARCH AND DEVELOPMENT - Research and development costs are charged to 
   expense when incurred.
   
   CASH EQUIVALENTS - Cash equivalents include money market securities 
   stated at cost, which approximate market value, purchased with original 
   maturities of three months or less.
   
   STOCK-BASED COMPENSATION - The Company accounts for stock-based awards 
   to employees using the intrinsic value method in accordance with APB No. 
   25, "Accounting for Stock Issued to Employees."  
   
4. ISSUANCE OF COMMON STOCK AND RELATED LITIGATION
   
   On July 11, 1996 the Company sold 1,585,000 shares of its common stock 
   to a private investor group at $1.125 per share, or $1,783,125 in gross 
   proceeds. In conjunction with the sale of common stock, the Company also 
   issued warrants to purchase an additional 1,585,000 shares of the 
   Company's common stock, exercisable at any time prior to July 15, 2001, 
   at an exercise price of $1.00 per share before July 15, 1997, $1.25 
   through July 1999 

                                        20

<PAGE>

   and $1.50 thereafter. Net proceeds received by the  Company related to 
   this placement were $1,525,237.
      
   On November 11, 1996, in connection with the approval by the 
   above-mentioned investors of a future additional offering of 
   common stock (relating to the Company's planned stock for stock exchange 
   to acquire the remaining 20% of common shares of SOC owned by the 
   original owners), the Company entered into an Amendment Agreement which 
   repriced the July 11, 1996 sale of common stock from $1.125 per share to 
   $.8352 per share and issued an additional 550,000 shares to the 
   investors.
   
   By letter dated January 13, 1997, counsel for Jalcanto, Ltd. and 
   Sabotini, Ltd. (the "Investors") notified the Company that these 
   Investors were electing to rescind the Share Purchase Agreements dated 
   July 10, 1996, as amended (the "Purchase Agreements"), under which  on 
   July 11, 1996 the Investors purchased a total of 2,135,000 shares of 
   common stock in the Company, and were demanding a refund by January 17, 
   1997 of the purchase price of such shares, or $1,783,125, plus interest. 
   The alleged ground for rescission is the fact that the Company's 
   registration statement on Form S-3 pertaining to the resale of such 
   shares was not declared effective by the SEC on or before December 31, 
   1996.  Subsequently, by letter dated February 3, 1997, counsel for the 
   Investors notified the Company that Jalcanto, Ltd. had retracted its 
   demand for rescission, with reservation of all rights. The letter 
   reiterated the rescission demand on behalf of Sabotini, Ltd., and the 
   request that the Company return $891,562.50.
   
   On February 5, 1997, the Company was served notice that it has been sued 
   by each of the Investors in the Superior Court of the State of California 
   for the County of Marin. Each Investor filed a complaint for breach of 
   contract, specific performance and indemnification relating to the 
   alleged failure to timely complete the contractually required 
   registration statement. In addition, each complaint requests that the 
   court issue a preliminary and permanent injunction against future 
   issuances of shares of the Company's common stock or securities 
   convertible into common stock without the Investor's consent. The 
   complaint filed by Sabotini Ltd. also requests rescission and the return 
   of the full purchase price of its shares (approximtely $892,000).  On 
   February 26, 1997, a hearing was held with respect to Sabotini's 
   application for a writ to attach the Company's funds in the amount of 
   $920,000 to ensure enforceability of any eventual judgment in Sabotini's 
   favor. By order dated February 28, 1997, the court denied the application 
   for the writ without prejudice. 
   
   The Company intends to defend itself vigorously in both actions and 
   believes that it is not probable that the Sabotini will prevail in 
   rescinding its Purchase Agreement. The Company may be required to expend 
   substantial funds and management resources in connection with the 
   defense and any settlement or judgment; accordingly, the ultimate 
   resolution of this litigation may have a material adverse effect on the 
   Company's business and financial condition taken as a whole. No provision 
   for any loss that may result from resolution of this uncertainty has been 
   made in the accompanying consolidated financial statements.
   
5. DISCONTINUED OPERATIONS
   
   On July 1, 1995 the Company sold Surmotech, Inc., a wholly owned 
   subsidiary, for $188,000 in cash. 

   On December 29, 1995 the Company sold Sayett Technology, Inc., (STI) a 
   wholly owned subsidiary, to former management members of the Company for 
   $300,000 in the form of a note receivable. In 1996, the Company received 
   $51,526 in cash and $15,069 in furniture 

                                        21

<PAGE>

   and fixtures. In the third quarter of 1996 the Company wrote 
   down the note by $121,702 based on their assessment of collectibility. 
   Based on events in the fourth quarter the Company wrote off the remaining 
   balance of $111,703. 
  
   As a result of the aforementioned sales, the Company is reporting the 
   results of the two subsidiaries as discontinued operations for the 
   period ended December 31, 1995 in the consolidated financial statements. 
   Net sales from discontinued operations were $5,462,000 in 1995.

6. PROPERTY AND EQUIPMENT 

   Property and equipment as of December 31 consist of the following:


                                                            1996       1995
                                                         ---------   --------
Office furniture and fixtures                            $ 94,885    $57,513
Machinery and equipment                                    62,263     58,255
                                                         --------    --------
                                                          157,148     115,768

Less accumulated depreciation and amortization             88,331      63,973
                                                         --------    --------
                                                         $ 68,817    $ 51,795
                                                         --------    --------
                                                         --------    --------

7. INVESTMENT IN SUBSIDIARY

   In November 1992, the Company entered into a Subscription and Stock 
   Purchase Agreement (the Agreement) with SOC (formerly WAH-III Technology 
   Corp.) a development stage company that develops, designs and 
   manufactures electronic display products, including a small, high 
   content liquid crystal display (LCD).  Through the Agreement and 
   subsequent amendments, the Company purchased and held, as of December 
   31, 1994, notes receivable totaling $1,078,105. Additionally, the 
   Company made advances to SOC under a line of credit agreement totaling 
   $200,000 as of December 31, 1994.
   
   On January 1, 1995, the Company converted its note receivable from SOC 
   and received 2,703,427 shares of SOC common stock which increased its 
   ownership of SOC to approximately 68%.  On February 7, 1995, the Company 
   exchanged 354,543 shares of its common stock for 531,815 shares of SOC 
   common stock, which further increased its ownership to approximately 
   80.3%.  The note receivable conversion and exchange of shares in 1995 
   gave rise to a difference between the Company's investment and the 
   underlying equity in the net assets of SOC.  This excess of purchase 
   price over the net assets acquired ("goodwill") totaled $1,475,965. 
   The Company wrote off the $1,475,965 of goodwill in December 1995, based 
   in part on a comparison of the Company's best estimate of the undiscounted 
   cash flows of SOC to the carrying value of the goodwill. 

                                        22

<PAGE>


   The operating results of SOC have been included in the Company's 
   consolidated financial statements since January 1, 1995.  The absence of 
   a minority interest balance on the consolidated balance sheet as of 
   December 31, 1996 and 1995 is due to a deficiency in SOC's net assets 
   due to its recurring losses.  Additionally, losses applicable to the 
   minority interest have been charged against the Company's interest, as 
   there is no obligation of the minority interest to make good such losses. 
   
8. LOSS IN INVESTEE COMPANY
   
   On March 26, 1994, the Company acquired 40% of the common stock of 
   InterVision Systems, Inc. (ISI), a newly formed Delaware Corporation 
   that produces head-mounted displays utilizing a wearable computer, for 
   $1,350,000. The Company accounted for this investment using the equity 
   method of accounting which required that the original investment be 
   recorded at cost and adjusted by the Company's share of undistributed 
   earnings or losses of ISI. ISI generated a loss of approximately 
   $925,286 for the period ended December 31, 1994. The Company lost an 
   additional $424,714 for the nine months ended September 30, 1995, 
   indicating that the Company's investment was and continued to be 
   significantly impaired. The Company measured the impairment of its 
   investment by recording 100% of the loss generated by ISI in the 
   consolidated financial statements since the Company essentially provided 
   100% of ISI's capitalization and therefore, had all the capital-at-risk. 
   As of December 31, 1995 Company's investment has been totally 
   written-off.

9. INCOME TAXES 

   The income tax provision including the effect of continuing and 
   discontinued operations in the accompanying consolidated statements 
   of operations is as follows:

                                                             1996     1995
                                                           --------  -------
    Current payable, primarily state taxes                 $(1,950) $(1,398)
                                                           --------  -------
                                                           --------  -------

   The income tax provision differs from those computed using the statutory 
   federal tax rate of 34%, due to the following:

                                        23

<PAGE>

<TABLE>
<CAPTION>
                                                                 1996         1995
                                                               --------     --------
<S>                                                            <C>          <C>
        Benefit at statutory federal rate                      $400,771     $948,801
        State benefit (taxes)                                    36,175       (1,398)
        Tax loss and credit carryforwards
          due to sale of subsidiaries generating
          those tax attributes                                 (116,891)           --
        Increase in valuation allowance                        (327,677)     (948,801)
        Other                                                     5,672            --
                                                              ---------       -------
                                                              $  (1,950)      $(1,398)
                                                              ---------       -------
                                                              ---------       -------
</TABLE>

   The net deferred tax assets (liabilities) as of December 31, 1996 and 
   1995 are as follows:


          CURRENT:
          Inventory reserves                $     --    $       --
          Bad debt reserves                    79,358           --
          Warranty liability                      --            --
          Other                                17,261           --
          Valuation allowance                 (96,619)          --
                                            ----------     -----------
                                            $      --     $      --
                                            ----------     -----------
                                            ----------     -----------

          NONCURRENT:
          Depreciation and amortization     $   (3,397)   $      --
          Equity in losses of investees      1,168,908      1,168,908
          State taxes, net                     337,277        222,905
          Operating loss carryforwards       1,584,608      1,515,752
          Federal tax credit                    51,227           --
          Less valuation allowance          (3,138,623)    (2,907,565)
                                            ----------    -----------
                                            $      --     $      --
                                            ----------    -----------
                                            ----------    -----------

   A valuation allowance is provided when it is more likely than not that 
   some portion of the deferred tax asset will not be realized. The Company 
   has established a 100% valuation allowance at December 31, 1996 and 1995 
   due to uncertainty of realizing future tax benefits from its net operating 
   loss carryforwards and other deferred tax assets.

   As discussed in Note 5, the Company sold two subsidiaries during 1995.
   Any tax benefits arising from the disposal of these subsidiaries were 
   completely offset by an increase in the Company's valuation allowance.

   At December 31, 1996, the Company had net operating loss ("NOL") 
   carry-forwards of approximately $4,700,000, available to offset United 
   States taxable income.  The NOL carry-forwards will expire from 2005 to 
   2011. 

   Income taxes (refunded) paid in 1996 and 1995 totaled $5,330 and 
   $(1,912) respectively.

                                        24

<PAGE>


10. STOCKHOLDERS' EQUITY

   STOCK OPTION PLAN - The Company has various Stock Option Plans primarily 
   for employees and directors.  The Plans authorize the issuance of 
   options to purchase up to 1,010,000 shares of the Company's common 
   stock.  The Plans provide for options which may be issued as 
   nonqualified or qualified incentive stock options under Section 422A of 
   the Internal Revenue Code of 1986, as amended.
   
   Under the 1991 and 1993 Employee Stock Option Plans, the Company may 
   grant options to purchase up to 915,000 shares of common stock to 
   employees at prices not less than the fair market value at the date of 
   grant for incentive stock options and not less than 85% of fair market 
   value for non-statutory stock options. These options expire 10 years 
   from the date of grant and become exercisable 50% in year one and 50% in 
   year two. 
   
   Under the 1993 Non-Employee Directors' Stock Option Plan non-employee 
   directors of the Company are granted options to purchase 10,000 shares 
   of common stock at the fair market value at the date of grant each year 
   that such person remains a director of the Company. These options expire 
   10 years from the date of grant and become fully exercisable after 2 
   years. The total number of shares authorized under the plan is 95,000. 

   Options under the Plans are granted at the discretion of the Board of 
   Directors. All options granted through 1996 have been granted at fair 
   market value. 
   
   The following is a status of the options under the Plans and a summary 
   of the changes in options outstanding during 1996 and 1995:
   

                                               Number of         Weighted Avg.
                                                Shares          Exercise Price
                                              ----------       ----------------
      Outstanding, January 1, 1995             443,500              $2.82
      Options granted                          195,300               1.62
      Options cancelled                       (428,800)              2.82
                                              --------
      Outstanding, December 31, 1995           210,000               2.42
      Options granted                          165,000               1.06
      Options canceled                         (10,000)              1.19
                                              --------
      Outstanding, December 31, 1996           365,000              $1.84
                                              --------
                                              --------

   Options exercisable as of December 31, 1996 and 1995 totaled 
   approximately 170,000 and 125,000 options at a weighted average exercise 
   price of $1.81 and $2.79 respectively.

                                        25

<PAGE>


   Additional information regarding options outstanding as of December 31, 
   1996 is as  follows:

                               OPTIONS OUTSTANDING      OPTIONS EXERCISABLE
                              ----------------------    -------------------
                              Weighted              
                              Average        Weighted               Weighted
                              Remaining      Average                Average
Range of        Number        Contractual    Exercise  Number       Exercise
Exercise Prices Outstanding   Life (Yrs)     Price     Exercisable  Price
- --------------- -----------   -----------    --------  -----------  --------
$2.00-$3.13     140,000       6.2            $2.82         140,000  $2.82 
$1.00-$2.00     160,000       8.9            $1.38          30,000  $1.69 
$0.875-$1.00     65,000       9.2            $0.88                  $0.88 
                -------                                 ----------
                365,000                                    170,000
                -------                                 ----------
                -------                                 ----------

   At December 31, 1996, 605,000 shares and 40,000 shares were available 
   for future grants under the Employee Stock Option Plan and Non-Employee 
   Directors Plan, respectively.
   
   ADDITIONAL STOCK PLAN INFORMATION
   
   Statement of Financial Accounting Standards No. 123, ACCOUNTING FOR 
   STOCK-BASED COMPENSATION, (SFAS 123) requires the disclosure of pro 
   forma net loss and loss per share had the Company adopted the fair value 
   method as of the beginning of fiscal 1995.  Under SFAS 123, the fair 
   value of stock-based awards to employees is calculated through the use 
   of option pricing models, even though such models were developed to 
   estimate the fair value of freely tradable, fully transferable options 
   without vesting restrictions, which significantly differ from the 
   Company's stock option awards. These models also require subjective 
   assumptions, including future stock price volatility and expected time 
   to exercise, which greatly affect the calculated values.  The Company's 
   calculations were made using the Black-Scholes option pricing model with 
   the following weighted average assumptions:  expected life, 10 years; 
   stock volatility, 183% in 1996 and 183% in 1995; risk free interest 
   rates, 6.89% in 1996 and 6.59% in 1995; and no dividends during the 
   expected term.  The Company's calculations are based on a multiple 
   option valuation approach and forfeitures are recognized as they occur. 
   If the computed fair values of the 1995 and 1996 awards had been 
   amortized to expense over the vesting period of the awards, pro forma 
   net loss would have been $4,714,233($.75 per share) in 1995 and 
   $1,299,513 ($0.18 per share) in 1996.  However, the impact of 
   outstanding non-vested stock options granted prior to 1995 has been 
   excluded from the pro forma calculation; accordingly, the 1995 and 1996 
   pro forma adjustments are not indicative of future period pro forma 
   adjustments, when the calculation will apply to all applicable stock 
   options. 

   On February 25, 1997 the Company repriced the exercise price and extended 
   vesting period of all 365,000 outstanding options (originally granted from 
   $0.875 to $3.13) to $0.625.


                                        26
<PAGE>

11. MAJOR CUSTOMERS

    The Company had five customers during the year ended December 31, 1995. 
    Two of these customers accounted for 40% of the Company's sales.
   
12. COMMITMENTS AND CONTINGENCIES

    The Company has various operating lease arrangements for equipment and 
    office space.  Total rent expense under operating leases amounted to 
    approximately $32,000 and $35,000 in 1996 and 1995, respectively.  The 
    office lease expires on April 30, 1997 and future minimum lease payments 
    under non-cancelable operating leases are $12,000. The Company expects 
    the lease to be renewed for one year.
   
    CONTINGENT PAYMENT CONTRACTS - Prior to December 31, 1994, SOC entered 
    into certain contracts with service providers and with several employees 
    to lease space and obtain research, development, marketing, legal and 
    other services. These contracts provide for payments to these service 
    providers and employees as SOC achieves specified cumulative unit sales 
    or revenue levels.  There are no required payments under the contracts 
    if minimum cumulative unit sales or revenue levels are not achieved.  
    The contracts do not have expiration dates.  As of December 31, 1996 and 
    1995, services under these contracts have been provided to the Company; 
    however, no amounts have been accrued as a liability because achievement 
    of the minimum required cumulative unit sales or revenue levels is not 
    considered probable as of that date.  As of December 31, 1996, the 
    maximum potential liability of the Company under these contracts is 
    approximately $1,100,000.




ITEM 8.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
         FINANCIAL DISCLOSURE.

                                    Not applicable




                                       PART III
                                           
ITEM 9.  DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS;
         COMPLIANCE WITH SECTION 16(a) OF THE EXCHANGE ACT.

The information required by this Item is incorporated by reference from 
the definitive proxy statement for the Company's 1997 annual meeting of 
stockholders to be filed with the Commission pursuant to Regulation 14A 
not later than 120 days after the end of the fiscal year covered by this 
report (the "Proxy Statement") under the caption "DIRECTORS, EXECUTIVE 
OFFICERS, PROMOTERS AND CONTROL PERSONS: COMPLIANCE WITH SECTION 16(a) OF 
THE EXCHANGE ACT."

ITEM 10. EXECUTIVE COMPENSATION

The information required by this Item is incorporated by reference from 
the Proxy Statement under the caption "EXECUTIVE COMPENSATION."

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The information required by this Item is incorporated by reference from 
the Proxy Statement under the caption "SECURITY OWNERSHIP OF CERTAIN 
BENEFICIAL OWNERS AND MANAGEMENT."

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

The information required by this Item is incorporated by reference from 
the Proxy Statement under the caption "CERTAIN RELATIONSHIPS AND RELATED 
TRANSACTIONS."

                                         27
<PAGE>

ITEM 13. EXHIBITS AND REPORTS ON FORM 8-K.

       (a)  The following exhibits are filed as part of this Form 10-KSB:
     
       Exhibit #                  Description
       ---------                  -----------

        3.1         Certificate of Incorporation 
        3.2         By-laws 
       10.1(1)*     1991 Stock Option Plan 
       10.2(1)*     Form of Officers and Directors Agreement
       10.3(1)*     Employee Stock Option Plan
       10.4(1)*     Director Stock Option Plan
       10.5(1)      Agreement between Sayett Group, Inc. and InterVision 
                    Systems, Inc. dated March 11, 1994
       10.6(2)      Agreement and Plan of Reorganization, dated January 26, 1995
       10.7(2)      Sayett Group, Inc. and WAH-III Technology Subscription and 
                    Stock Purchase Agreement, dated November 25, 1992
       10.8(2)      Amendment to Subscription and Stock Purchase Agreement, 
                    dated June 29, 1993
       10.9(2)      Second Amendment to Subscription and Stock Purchase 
                    Agreement, dated April 27, 1994
       10.10(2)     Stock Purchase Agreement, dated July 19, 1994
       10.11(3)     Share Purchase Agreements dated July 10, 1996 between 
                    the Company and each of Jalcanto, Ltd. and Sabotini, Ltd.
       10.12(4)     Agreement and Warrant to Purchase 792,500 Common 
                    Shares of Spatialight, Inc. as issued to each of Jalcanto, 
                    Ltd. and Sabotini, Ltd.
       10.13(5)     Amendment to Share Purchase Agreements dated November 11,
                    1996 with each of Jalcanto, Ltd. and Sabotini, Ltd.
       10.14*       Employment Agreement between the Company and William E. 
                    Hollis dated July 1, 1996
       10.15*       Employment Agreement between the Company and Dean S. 
                    Irwin dated July 1, 1996
       10.16        Distribution Agreement between Spatialight of California 
                    and Meadowlark Optics
       10.17*       Employment agreement between the Company and L. John 
                    Loomis dated February 17, 1997
       27.1         Financial Data Schedule




         *   Designates management contracts and compensatory plans.

        (1)  Incorporated by reference to the corresponding exhibit filed 
             with the registrant's Registration Statement on Form S-1 filed
             February 13, 1992, as amended.
  
        (2)  Incorporated by reference to the corresponding exhibit filed 
             with the registrant's Current Report on Form 8-K filed 
             February 7, 1995.

        (3)  Incorporated by reference to exhibit 10.32 filed with     
             the registrant's Current Report on Form 8-KA filed September  
             24, 1996.

        (4)  Incorporated by reference to exhibit 4.5 filed with the
             registrant's Current Report on Form 8-KA filed September 24, 
             1996.

        (5)  Incorporated by reference to exhibit 10.33 filed with 
             the registrant's Current Report on Form 8-KA filed November 
             11, 1996.

        (b)  No Form 8-K was filed during the quarter ended December 31, 1996.
             A Form 8-KA was filed on November 11, 1996 reporting under 
             Item 5, and amending a Form 8-K originally filed on July 23, 
             1996.




<PAGE>

                                      SIGNATURES
                                           
                                           
    In accordance with Section 13 or 15(d) of the Exchange Act, the 
Registrant caused this report to be signed on its behalf by the undersigned, 
thereunto duly authorized.

                                            SPATIALIGHT, INC.


Dated: March 31, 1997                By: /s/ William E. Hollis
                                         ----------------------------------
                                          William E. Hollis
                                          President & Chief Executive Officer
                                          Chief Financial Officer and
                                          Chief Accounting Officer

    In accordance with the Exchange Act, this Report has been signed below by 
the following persons on behalf of the Registrant and in the capacities and 
on the dates indicated:

Dated: March 31, 1997                By: /s/ William E. Hollis
                                         ----------------------------------
                                          William E. Hollis
                                          President & Chief Executive Officer
                                          Chief Financial Officer and
                                          Chief Accounting Officer

Dated: March 31, 1997                By: /s/ Lawrence J. Matteson
                                        ----------------------------------
                                          Lawrence J. Matteson
                                          Chairman of the Board


Dated: March 31, 1997                By: /s/ Michael H. Burney
                                        ----------------------------------
                                          Michael H. Burney
                                          Director

Dated: March 31, 1997                By: /s/ Edward J. Kelly
                                        ----------------------------------
                                          Edward J. Kelly
                                          Director

Dated: March 31, 1997                By: /s/ Thomas D. Stahl
                                        ----------------------------------
                                          Thomas D. Stahl
                                          Director



<PAGE>
                                                           EXHIBIT 10.14

                                EMPLOYMENT AGREEMENT



     THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into as of July 1, 
1996, by and between SPATIALIGHT, INC., A NEW YORK CORPORATION ("Company"), 
and WILLIAM E. HOLLIS ("Employee") , with reference to the following facts:

                                    RECITALS

     A. Employee is currently employed by Company.

     B. Company and Employee wish to enter into this Agreement to  assure
        Company of the services of Employee and to set forth the rights and
        duties of the parties.

NOW THEREFORE, the parties agree as follows:

                                    AGREEMENT

     1.   EMPLOYMENT.

          (a) Company hereby employs Employee as its Chief Executive Officer, 
and Employee hereby accepts and agrees to said employment by the Company for 
the purpose of rendering on behalf of Company services as a Chief Executive 
Officer, upon the terms and conditions set forth herein.

          (b)  Employee shall perform such services and duties with the 
Company as are usually associated with the position of Chief Executive 
Officer and as otherwise decided upon by the Board of Directors of the 
Company.  Employee shall report directly to the Board of Directors of 
Company.  Employee further agrees that, except during vacation periods or in 
accordance with Company's personnel policies covering leaves of absence and 
reasonable periods of illness or other incapacitation, Employee shall devote 
substantially all of his time and services to the business and interests of 
the Company.  Notwithstanding the foregoing, Employee shall also be permitted 
to serve on the boards of directors of other business corporations and may 
participate in charitable, cultural, professional, civic and business 
association activities.  Employee shall perform the duties of his position 
and those assigned to him by the Company's Board of Directors with fidelity, 
to the best of his ability, in the best interests of the Company, in a 
professional manner and at all times in compliance with all laws, rules and 
regulations.  Employee agrees that to the best of his ability and experience 
he will at all times loyally and conscientiously perform all of the duties 
and obligations required of him either expressly or implicitly by the terms 
of this Agreement.  Additionally, Employee agrees to comply with corporate 
policies, standards and regulations adopted by the Company from


<PAGE>

time to time to the extent the same are reasonable and not in violation of law.

     2.    TERM OF EMPLOYMENT.

     Employee's term ("Term") of employment by the Company as set forth 
herein shall commence as of the date of this Agreement (the "Effective 
Date") and shall continue thereafter for a period of three years unless 
otherwise terminated pursuant to the provisions of Section 7 below.  
Notwithstanding the foregoing, the Term shall automatically be renewed, upon 
the same terms and conditions contained herein, for consecutive periods of 
one year each (a "Renewal Term") upon expiration of the immediately preceding 
term unless and until either party elects not to so renew this Agreement by 
delivering written notice to the other party not less than thirty (30) days 
prior to the expiration of the Term, or any then existing Renewal Term.  
Nothing in this Section shall be deemed or construed as limiting or waiving 
any of the rights of Company or Employee set forth in Section 7.

     3.    COMPENSATION.

          a.   Salary - Upon the Effective Date, the Company shall pay 
Employee a salary ("Salary") at the annual rate equal to One Hundred Twenty 
Thousand Dollars ($120,000). Employee's Salary shall be paid pursuant to 
Company's normal payroll practices. Company shall have the right to deduct 
from the compensation due to Employee hereunder any and all sums required for 
social security and withholding taxes, and for any other federal, state or 
local charge and/or tax which may now be in effect or is hereafter enacted or 
required as a charge on the compensation of Employee.

          b.   Benefits - Employee shall be entitled to the following 
benefits provided by the Company: (i) a suitable office and furnishings 
commensurate with Employee's position and such related facilities as are 
necessary for the performance of Employee's duties, (ii) medical and dental 
insurance, providing coverage on terms no less beneficial than those afforded 
other senior executives employed by the Company, (iii) 4 weeks of paid 
vacation per year earned pro-rata over each year of the Term and (iv) 1 week 
of paid sick-leave per year earned pro-rata over each year of the Term.  
Employee acknowledges and agrees that some of the benefits provided to 
Employee by Company hereunder may be taxable to Employee, and that Company 
may be required to make payroll withholdings in respect of such taxable 
benefits.

          c.  Bonuses - Employee shall be entitled to receive bonuses from 
time to time in such amounts, as the Company's Board of Directors may 
determine in its sole and absolute discretion.

<PAGE>

     4.   EMPLOYEE EXPENSES.

     Employee shall be responsible for payment of all personal business 
expenses incurred by Employee, including entertainment, automobile and travel 
related expenses and expenses relating to professional organizations.  
Subject to Company's prior approval, and upon submission of a detailed 
accounting supported by receipts, Company shall reimburse Employee for all 
expenses incurred by Employee at Company's specific request.

     5.   CONFIDENTIAL INFORMATION.

          a.   Within the scope of his employment hereunder, Employee will 
have access to confidential information and trade secrets relating to 
Company's business.  This confidential information and trade secrets 
includes, but is not limited to, know-how, research and development, 
marketing strategy, sales methods and expertise, customer lists, confidential 
records and data pertaining to Company's customers and other customer 
information, and all other information owned by Company and regularly used in 
the operation of the business of Company, including, without limitation, all 
lists, books, records, files documents and similar items relating to the 
business or products of Company, whether prepared by Employee or otherwise 
coming into Employee's possession; all of the foregoing being deemed 
"Confidential Information".  Employee and Company agree that all such 
Confidential Information consists of protectable trade secrets and 
confidential information within the meaning of California Civil Code Section 
3426 ET SEQ. and all other applicable provisions of California law. Employee 
agrees that, during the term and continuance of his employment by Company, and 
for the 2 year period commencing on the date of termination of said 
employment for any reason whatsoever, he will not directly or indirectly make 
known, disclose or divulge to any person, firm, entity or corporation any of 
the Confidential Information described herein unless Employee is specifically 
authorized to do so in writing by Company.  The provisions of this Section 
apply to all Confidential Information of Company which Employee may develop, 
obtain or learn about during or as a result of his employment by Company, 
whether such Confidential Information is prepared by Employee or comes into 
Employee's possession in any other way and whether or not it contains or 
constitutes trade secrets owned by Company.

          b.   Employee acknowledges and agrees that all Confidential 
Information is and shall remain the exclusive property of Company and shall 
not be removed from the premises of Company under any circumstances 
whatsoever (provided that if such removal is necessitated to perform 
Employee's duties hereunder, then such removal shall be permitted on a 
temporary basis to perform such activities) without the prior written consent 
of Company.  Upon termination of employment for any reason, all such 
Confidential Information, whether prepared by Employee or otherwise coming 
into

<PAGE>

Employee's possession, shall be immediately returned to Company by Employee.

          c . Employee acknowledges that he has not disclosed, and is not 
required as a condition of employment to disclose, to Company any 
confidential information which is owned by any of his prior employers.

          d.   If Employee should materially breach any of his covenants 
under this Section 5, then in addition to all other rights or remedies 
provided for hereunder or at law or in equity, Company shall have the 
immediate right to terminate Employee's employment with Company (such 
termination to be deemed for "cause" as set forth in Section 7.a. below) 
and/or Company shall be entitled to injunctive relief without the posting of 
bond or other security, since the remedy at law would be inadequate and 
insufficient.  In addition, Company shall be entitled to such damages as it 
can show it has sustained by reason of Employee's breach.  Furthermore, 
Employee agrees to defend, indemnify and hold Company and its shareholders, 
directors, officers, agents and employees, and their successors, assigns and 
heirs, harmless from and against any and all claims (including third-party 
claims) arising from or in connection with any breach or default by Employee 
in Employee's covenants under this Section 5, together with all costs, 
expenses and liabilities incurred in, or in connection with, each such claim 
or action or proceeding brought thereon, including, without limitation, 
reasonable attorneys fees and costs.  The provisions of this Section 5 shall 
apply to any breach by Employee occurring during the term of his employment 
and/or during the 2 years after termination of his employment for any reasons 
whatsoever.

     6.   DEVELOPMENT/OWNERSHIP OF NEW PROCEDURES.

          a.   All know-how, expertise, procedures, processes, products, 
inventions, patents, copyrights, trademarks, service marks and other 
intangible rights (hereinafter collectively "inventions") that may be 
conceived or developed by Employee, either alone or with others, during the 
term of Employee's employment, whether or not conceived or developed during 
Employee's working hours, and with respect to which any equipment, supplies, 
facilities, know-how, expertise or trade secret information of Company was 
used, or that relate, at the time of conception or reduction to practice of 
the invention, procedure, process, or item subject to patent, copyright or 
similar protection, or other intangible right, to the business of Company or 
to Company's actual or demonstrably anticipated research and development, or 
that relate to or result from any work performed by Employee for Company, 
shall be disclosed to Company during the term of Employee's employment and 
for 2 years thereafter.  To the extent the Company does not have rights 
therein hereunder, such disclosure shall be received by the Company in 
confidence and does not extend the assignment made in Section 6(b) below.

<PAGE>

          b. All inventions which Employee makes, conceives, practice or 
develop (in whole or in part, either alone or jointly with others) during his 
employment by Company shall be the sole property of the Company to the 
maximum extent permitted by Section 2870 of the California Labor Code, a copy 
of which is attached hereto as Exhibit "A", and to the extent permitted by 
law shall be "works made for hire".  Company shall be the sole owner of all 
patents, copyrights, trade secret rights, rights with respect to mask works 
and other intellectual property or other rights in connection therewith 
unless agreed in writing to the contrary by the Company.  Employee hereby 
assigns to Company any rights he may have or acquire in such inventions.  
Employee agrees to perform, during and after employment with Company, all 
acts deemed necessary or desirable by Company to permit and assist it, at 
Company's expense, in obtaining and enforcing patents, copyrights, trade 
secret rights, rights with respect to mask works or other rights on such 
inventions and/or any other inventions Employee have or may at any time 
assign to Company in any and all countries.  Such acts may include, but are 
not limited to, execution of documents and assistance or cooperation in legal 
proceedings.  Employee hereby irrevocably designates and appoints Company and 
its duly authorized officers and agents, as his agents and attorneys-in-fact 
to act for and in his behalf and instead of him, to execute and file any 
applications or related filings and to do all other lawfully permitted acts 
to further the prosecution and issuance of patents, copyrights, trade secret 
rights, rights with respect to mask works or other rights thereon with the 
same legal force and effect as if executed by Employee.

           c.  If Employee should breach any of his covenants under this 
Section 6, then in addition to all other rights or  remedies provided for 
hereunder or at law or in equity, the Company shall have the immediate right 
to terminate Employee's employment  with the Company and/or the Company shall 
be entitled to injunctive relief without the posting of bond or other 
security, since the  remedy at law would be inadequate and insufficient.  In 
addition, the Company shall be entitled to such damages as it can show it has 
sustained by reason of Employee's breach.  Furthermore, Employee agrees to 
defend, indemnify and hold Company and its shareholders,  partners, 
directors, officers, agents and employees, and their successors, assigns and 
heirs, harmless from and against any and all  claims (including third-party 
claims) arising from or in connection with any breach or default by Employee 
in Employee's covenants  under this Section 6, together with all costs, 
expenses and liabilities incurred in, or in connection with, each such claim 
or action  or proceeding brought thereon, including, without limitation, 
reasonable attorneys fees and costs.

      7.  TERMINATION.

           a.  Company may terminate this Agreement and Employee's employment 
at any time prior to the expiration of the  Term or any

<PAGE>

Renewal Term for "cause". For the purposes of this Agreement, "cause" shall 
mean:

                (i) Employee's continued willful and habitual neglect of his 
         duties following notification of such neglect by Company's Board of 
         Directors and failure by Employee to cure such neglect within 30 days 
         after such notification.

               (ii) Employee's conviction, after the date hereof, of a 
         felony which, by its nature, would materially injure the reputation 
         of Company as determined by Company's Board of Directors acting in 
         good faith and upon reasonable grounds.

              (iii) Employee's incapacity to perform the duties required 
         of him hereunder as a result of mental or physical illness, which 
         incapacity continues for a period of 180 days in any 12 consecutive 
         month period.

               (iv) Company ceases or fails to continue to do business.

                (v) Death of the Employee.

Termination of Employee's employment for cause shall not be in limitation of 
any other right or remedy Company may have under this Agreement or in law or 
equity.

          b.   Notwithstanding the termination of this Agreement pursuant to 
Section 7a herein or as a result of the expiration of the Term or any Renewal 
Term, this Section 7b and Sections 5, 7a, 8, 9, 10, 11, 12, 13, 14, 15, 161 
17 and 18 herein shall remain in full force and effect.

     8.   NON-COMPETE.

     As a material inducement for Company to enter into this Agreement, 
Employee agrees that for a period of 2 years following the termination of 
this Agreement for any reason whatsoever, Employee will not directly or 
indirectly (i) solicit, or agree to service for his benefit or the benefit of 
any third-party, any of Company's customers whether or not serviced directly 
by Employee during the term of this Agreement and (ii) disrupt, damage, 
impair or interfere with the business of Company, whether by way of breaching 
any obligation under this Agreement, interfering with any customer of 
Company, Company's employees, disrupting Company's relationships with 
customers, agents, representatives or vendors or otherwise.

     9.    REASONABLENESS.

     The parties recognize that this Agreement contains conditions, 
covenants, and time limitations that are reasonably required for the 
protection of the confidential information, trade secrets and

<PAGE>

business of the parties or a particular party.  If any limitation, covenant 
or condition shall be deemed to be unreasonable and unenforceable by a court 
or arbitrator of competent jurisdiction, then this Agreement shall 
thereupon be deemed to be amended to provide for modification of such 
limitation, covenant and/or condition to such extent as the court or 
arbitrator shall find to be reasonable and such modification shall not affect 
the remainder of this Agreement.

     10. REMEDIES.

     No remedy conferred by any of the specific provisions of this Agreement 
is intended to be exclusive of any other remedy given hereunder or hereafter 
existing at law or in equity.  The election of any one or more remedies by 
any party shall not constitute a waiver of the right to pursue other 
available remedies.

     11. SEVERABLE PROVISIONS.

     The provisions of this Agreement are severable, and if any one or more 
provisions may be determined to be judicially unenforceable, in whole or in 
part, the remaining provisions shall nevertheless be binding and enforceable.

     12. INJUNCTIVE RELIEF.

     Employee acknowledges that, in the event Employee breaches this 
Agreement, money damages will not be adequate to compensate Company for the 
loss occasioned by such breach.  Employee, therefore, consents, in the event 
of such a breach, to the granting of injunctive relief against Employee by 
any court of competent jurisdiction.

     13. BINDING AGREEMENT.

     The rights and obligations of the parties under this Agreement shall 
inure to the benefit of and shall be binding on their successors and assigns. 
 Notwithstanding the foregoing, Employee may not assign his rights or 
obligations hereunder.

     14. NOTICES.

     Any notice to be given to the Company under the terms of this Agreement 
shall be addressed to the Company at the address of its principal place of 
business, and any notice to be given to Employee shall be addressed to him at 
his home address last shown on the records of the Company, or at such other 
address as either party may hereafter designate in writing to the other.  All 
notices shall be in writing and shall be delivered personally, sent by United 
States certified or registered mail, return receipt requested, first class 
postage prepaid, or by private messenger or courier service.  Any such notice 
shall be deemed to have been received on

<PAGE>

the earlier of (i) five (5) business days after it is mailed or (ii) the date 
it is actually received.

     15.   WAIVER.

     Either party's failure to enforce any provision or provisions of this 
Agreement shall not in any way be construed as a waiver of any such 
provision, or prevent that party thereafter from enforcing each and every 
other provision of this Agreement.

     16.   TITLE AND HEADINGS.

     Titles and headings to sections in this Agreement are for the purpose of 
reference only and shall in no way limit, define, or otherwise affect the 
provisions of it.

     17.   ATTORNEYS' FEES AND COSTS OF LITIGATION.

     In any action at law or in equity to enforce any of the provisions or 
rights under this Agreement, the unsuccessful party, as determined by the 
court in a final judgment or decree, shall pay the successful party all 
costs, expenses and attorneys' fees actually incurred by the successful party 
(including, without limitation, the costs, expenses and attorneys fees on any 
appeal) and if the successful party shall recover a judgment in any such 
action or proceeding, the costs, expenses and attorneys, fees shall be 
included as part of the judgment.

     18.   GOVERNING LAW.

     The parties hereto agree that it is their intention and covenant that 
this Agreement and performance under it, and all suits and 
special proceedings that may ensue from its breach, be construed in 
accordance with and under the laws of the State of California, and that in 
any action, special proceeding, or other proceeding that may be brought 
arising out of, in connection with, or by reason of this Agreement, the laws 
of the State of California shall be applicable and shall govern to the 
exclusion of the law of any other forum, without regard to the jurisdiction 
in which any action or special proceeding may be instituted.

     19.   WAIVER OF JURY TRIAL.

     Company and Employee hereby agree to waive their respective rights to a 
jury trial of any claim or cause of action raised upon or arising out of this 
Agreement.  The scope of this waiver is intended to be all encompassing of 
any and all disputes that may be filed in any court and that relate to the 
subject matter of this transaction, including without limitation, contract 
claims, tort claims, breach of duty claims, and all other common law and 
statutory claims.  Company and Employee each acknowledge that this waiver is 
a material inducement for Company and Employee to enter into a business 
relationship, that Company and Employee have

<PAGE>

already relied on this waiver in entering into this Agreement and that each 
will continue to rely on this waiver in their related future dealings.  
Company and Employee further warrant and represent that each has reviewed 
this waiver with its legal counsel, and that each knowingly and voluntarily 
waives its jury trial rights following consultation with legal counsel.  This 
waiver is irrevocable, meaning that it may not be modified either orally or 
in writing, and this waiver shall apply to any subsequent amendments, 
renewals, supplements or modifications to this Agreement.  In the event of 
litigation, this Agreement may be filed as a written consent to a trial by 
court.


          EMPLOYEE'S INITIALS             COMPANY'S INITIALS

      IN WITNESS WHEREOF, the parties hereto have executed this Agreement as 
of the day and year first above written.

"Company"                                 "EMPLOYEE"

 .SPATIALIGHT, INC.,
A NEW YORK CORPORATION

                                           ------------------------
                                           WILLIAM E. HOLLIS

 BY:
 NAME: LAWRENCE MATTESON
 TITLE:  CHAIRMAN OF BOARD

<PAGE>

                                    EXHIBIT A




       2870. APPLICATION OF PROVISION PROVIDING THAT EMPLOYEE SHALL ASSIGN OR 
OFFER TO ASSIGN RIGHTS IN INVENTION TO EMPLOYER.

(a)  Any provision in an employment agreement which provides that an employee 
shall assign, or offer to assign, any of his or her rights in an invention to 
his or her employer shall not apply to an invention that the employee 
developed entirely on his or her own time without using the employer's 
equipment, supplies, facilities, or trade secret information except for those 
inventions that either:

     (1)  Relate at the time of conception or reduction to practice of the 
invention to the employer's business, or actual or demonstrably anticipated 
research or development of the employer.

     (2)  Result from any work performed by the employee for the employer.

(b)  To the extent a provision in an employment agreement purports to require 
an employee to assign an invention otherwise excluded from being required to 
be assigned under subdivision (a), the provision is against the public policy 
of this state and is unenforceable.


<PAGE>

                                                               EXHIBIT 10.15
                                 EMPLOYMENT AGREEMENT


    THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into as of July 1, 
1996, by and between SPATIALIGHT, INC., A NEW YORK CORPORATION ("Company"),  
DEAN S. IRWIN ("Employee"), with reference to the following facts:

                                       RECITALS
                                       --------

    A.   Employee is currently employed by Company.

    B.   Company and Employee wish to enter into this Agreement to assure 
         Company of the services of Employee and to set forth the rights and
         duties of the parties.

NOW THEREFORE, the parties agree as follows:

                                      AGREEMENT
                                      ---------

    1.   EMPLOYMENT.

    (a)  Company hereby employs Employee as its  Vice President Engineering, 
and Employee hereby accepts and agrees to said employment by the Company for 
the purpose of rendering on behalf of Company services as primary engineering 
manager, upon the terms and conditions set forth herein.

    (b)  Employee shall perform such services and duties with the Company as 
are usually associated with the position of  Vice President Of Engineering  
and as otherwise decided upon by  the President of  the Company. Employee 
further agrees that, except during vacation periods or in accordance with 
Company's personnel policies covering leaves of absence and reasonable 
periods of illness or other incapacitation, Employee shall devote 
substantially all of his time and services to the business and interests of 
the Company. Notwithstanding the foregoing, Employee shall also be permitted 
to serve on the boards of directors of other business corporations and may 
participate in charitable, cultural, professional, civic and business 
association activities. Employee shall perform the duties of his position and 
those assigned to him by the Company's Board of Directors with fidelity, to 
the best of his ability, in the best interests of the Company, in a 
professional manner and at all times in compliance with all laws, rules and 
regulations.  Employee agrees that to the best of his ability and experience 
he will at all times loyally and conscientiously perform all of the duties 
and obligations required of him either expressly or implicitly by the terms 
of this Agreement.  Additionally, Employee agrees to comply with corporate 
policies, standards and regulations adopted by the Company from 


<PAGE>

time to time to the extent the same are reasonable and not in violation of 
law.

    2.    TERM OF EMPLOYMENT.

    Employee's term ("Term") of employment by the Company as set forth herein 
shall commence as of the date of this Agreement (the "Effective Date,) and 
shall continue thereafter for a period of  two years unless otherwise 
terminated pursuant to the provisions of Section 7 below.  Notwithstanding 
the foregoing, the Term shall automatically be renewed, upon the same terms 
and conditions contained herein, for consecutive periods of one year each (a 
"Renewal Term") upon expiration of the immediately preceding term unless and 
until either party elects not to so renew this Agreement by delivering 
written notice to the other party not less than thirty (30) days prior to the 
expiration of the Term, or any then existing Renewal Term.  Nothing in this 
Section shall be deemed or construed as limiting or waiving any of the rights 
of Company or Employee set forth in Section 7.

    3.   COMPENSATION.

    a.   Salary - Upon the Effective Date, the Company shall pay Employee a  
         salary ("Salary") at the annual rate equal to  Ninety-six Thousand 
         Dollars ($96,000). Employee's Salary shall be paid pursuant to 
         Company's normal payroll practices. Company shall have the right to 
         deduct from the compensation due to Employee hereunder any and all 
         sums required for social security and withholding taxes, and for 
         any other federal, state or local charge and/or tax which may now 
         be in effect or is hereafter enacted or required as a charge on the 
         compensation of Employee.

    b.   Benefits - Employee shall be entitled to the following benefits 
provided by the Company: (i) a suitable office and furnishings commensurate 
with Employee's position and such related facilities as are necessary for the 
performance of Employee's duties, (ii) medical and dental insurance, 
providing coverage on terms no less beneficial than those afforded other 
senior executives employed by the Company, (iii) 4 weeks of paid vacation per 
year earned pro-rata over each year of the Term and (iv) 1 week of paid 
sick-leave per year earned pro-rata over each year of the Term.  Employee 
acknowledges and agrees that some of the benefits provided to Employee by 
Company hereunder may be taxable to Employee, and that Company may be 
required to make payroll withholdings in respect of such taxable benefits.

    C.   Bonuses - Employee shall be entitled to receive bonuses from time 
         to time in such amounts, as the Company's Board of Directors may 
         determine in its sole and absolute discretion.

<PAGE>

    4.   EMPLOYEE EXPENSES.

    Employee shall be responsible for payment of all personal 
business expenses incurred by Employee, including entertainment, 
automobile and travel related expenses and expenses relating to 
professional organizations.  Subject to Company's prior approval, 
and upon submission of a detailed accounting supported by receipts, 
Company shall reimburse Employee for all expenses incurred by 
Employee at Company's specific request.

    5.   CONFIDENTIAL INFORMATION.

    a.   Within the scope of his employment hereunder, Employee will have 
access to confidential information and trade secrets relating to Company's 
business.  This confidential information and trade secrets includes, but is 
not limited to, know-how, research and development, marketing strategy, sales 
methods and expertise, customer lists, confidential records and data 
pertaining to Company's customers and other customer information, and all 
other information owned by Company and regularly used in the operation of the 
business of Company, including, without limitation, all lists, books, 
records, files documents and similar items relating to the business or 
products of Company, whether prepared by Employee or otherwise coming into 
Employee's possession; all of the foregoing being deemed "Confidential 
Information".  Employee and Company agree that all such Confidential 
Information consists of protectable trade secrets and confidential 
information within the meaning of California Civil Code Section 3426 et SEQ. 
and all other applicable provisions of California law.  Employee agrees that, 
during the term and continuance of his employment by Company, and for the 2 
year period commencing on the date of termination of said employment for any 
reason whatsoever, he will not directly or indirectly make known, disclose or 
divulge to any person, firm, entity or corporation any of the Confidential 
Information described herein unless Employee is specifically authorized to do 
so in writing by Company.  The provisions of this Section apply to all 
Confidential Information of Company which Employee may develop, obtain or 
learn about during or as a result of his employment by Company, whether such 
Confidential Information is prepared by Employee or comes into Employee's 
possession in any other way and whether or not it contains or constitutes 
trade secrets owned by Company.

    b.   Employee acknowledges and agrees that all Confidential Information 
is and shall remain the exclusive property of Company and shall not be 
removed from the premises of Company under any circumstances whatsoever 
(provided that if such removal is necessitated to perform Employee's duties 
hereunder, then such removal shall be permitted on a temporary basis to 
perform such activities) without the prior written consent of Company.  Upon 
termination of employment for any reason, all such Confidential Information, 
whether prepared by Employee or otherwise coming into

<PAGE>

Employee' s possession, shall be immediately returned to Company by Employee.

    c . Employee acknowledges that he has not disclosed, and is not required 
as a condition of employment to disclose, to Company any confidential 
information which is owned by any of his prior employers.

    d.   If Employee should materially breach any of his covenants under this 
Section 5, then in addition to all other rights or remedies provided for 
hereunder or at law or in equity, Company shall have the immediate right to 
terminate Employee's employment with Company (such termination to be deemed 
for "cause" as set forth in Section 7.a. below) and/or Company shall be 
entitled to injunctive relief without the posting of bond or other security, 
since the remedy at law would be inadequate and insufficient.  In addition, 
Company shall be entitled to such damages as it can show it has sustained by 
reason of Employee's breach.  Furthermore, Employee agrees to defend, 
indemnify and hold Company and its shareholders, directors, officers, agents 
and employees, and their successors, assigns and heirs, harmless from and 
against any and all claims (including third-party claims) arising from or in 
connection with any breach or default by Employee in Employee's covenants 
under this Section 5, together with all costs, expenses and liabilities 
incurred in, or in connection with, each such claim or action or proceeding 
brought thereon, including, without limitation, reasonable attorneys fees and 
costs.  The provisions of this Section 5 shall apply to any breach by 
Employee occurring during the term of his employment and/or during the 2 
years after termination of his employment for any reasons whatsoever.

    6.   DEVELOPMENT/OWNERSHIP OF NEW PROCEDURES.

    a.   All know-how, expertise, procedures, processes, products, 
inventions, patents, copyrights, trademarks, service marks and other 
intangible rights (hereinafter collectively "inventions") that may be 
conceived or developed by Employee, either alone or with others, during the 
term of Employee's employment, whether or not conceived or developed during 
Employee's working hours, and with respect to which any equipment, supplies, 
facilities, know-how, expertise or trade secret information of Company was 
used, or that relate, at the time of conception or reduction to practice of 
the invention, procedure, process, or item subject to patent, copyright or 
similar protection, or other intangible right, to the business of Company or 
to Company's actual or demonstrably anticipated research and development, or 
that relate to or result from any work performed by Employee for Company, 
shall be disclosed to Company during the term of Employee's employment and 
for 2 years thereafter.  To the extent the Company does not have rights 
therein hereunder, such disclosure shall be received by the Company in 
confidence and does not extend the assignment made in Section 6(b) below.

<PAGE>

    reduces to   b. All inventions which Employee makes, conceives, practice 
    or develop (in whole or in part, either alone or jointly with others) 
    during his employment by Company shall be the sole property of the 
    Company to the maximum extent permitted by Section 2870 of the 
    California Labor Code, a copy of which is attached hereto as Exhibit 
    "A", and to the extent permitted by law shall be "works made for hire".  
    Company shall be the sole owner of all patents, copyrights, trade secret 
    rights, rights with respect to mask works and other intellectual 
    property or other rights in connection therewith unless agreed in 
    writing to the contrary by the Company. Employee hereby assigns to 
    Company any rights he may have or acquire in such inventions.  Employee 
    agrees to perform, during and after employment with Company, all acts 
    deemed necessary or desirable by Company to permit and assist it, at 
    Company's expense, in obtaining and enforcing patents, copyrights, trade 
    secret rights, rights with respect to mask works or other rights on such 
    inventions and/or any other inventions Employee have or may at any time 
    assign to Company in any and all countries.  Such acts may include, but 
    are not limited to, execution of documents and assistance or cooperation 
    in legal proceedings.  Employee hereby irrevocably designates and 
    appoints Company and its duly authorized officers and agents, as his 
    agents and attorneys-in-fact to act for and in his behalf and instead of 
    him, to execute and file any applications or related filings and to do 
    all other lawfully permitted acts to further the prosecution and 
    issuance of patents, copyrights, trade secret rights, rights with 
    respect to mask works or other rights thereon with the same legal force 
    and effect as if executed by Employee.

         C.   If Employee should breach any of his covenants under this 
Section 6, then in addition to all other rights or remedies provided for 
hereunder or at law or in equity, the Company shall have the immediate right 
to terminate Employee's employment with the Company and/or the Company shall 
be entitled to injunctive relief without the posting of bond or other 
security, since the remedy at law would be inadequate and insufficient.  In 
addition, the Company shall be entitled to such damages as it can show it has 
sustained by reason of Employee's breach.  Furthermore, Employee agrees to 
defend, indemnify and hold Company and its shareholders, partners, directors, 
officers, agents and employees, and their successors, assigns and heirs, 
harmless from and against any and all claims (including third-party claims) 
arising from or in connection with any breach or default by Employee in 
Employee's covenants under this Section 6, together with all costs, expenses 
and liabilities incurred in, or in connection with, each such claim or action 
or proceeding brought thereon, including, without limitation, reasonable 
attorneys fees and costs.

    7.   TERMINATION.

         a.   Company may terminate this Agreement and Employee's employment 
at any time prior to the expiration of the Term or any

<PAGE>

Renewal Term for "cause", For the purposes of this Agreement, "cause" shall 
mean:

         Employee's continued willful and habitual neglect of his duties 
    following notification of such neglect by Company's Board of Directors 
    and failure by Employee to cure such neglect within 30 days after such 
    notification.
    
         Employee's conviction, after the date hereof, of a felony which, by 
    its nature, would materially injure the reputation of Company as 
    determined by Company's Board of Directors acting in good faith and upon 
    reasonable grounds.
    
         Employee's incapacity to perform the duties required of him 
    hereunder as a result of mental or physical illness, which incapacity 
    continues for a period of 180 days in any 12 consecutive month period.

         (iv) Company ceases or fails to continue to do business.

         (v) Death of the Employee.

Termination of Employee's employment for cause shall not be in limitation of 
any other right or remedy Company may have under this Agreement or in law or 
equity.

        b.   Notwithstanding the termination of this Agreement pursuant to 
Section 7a herein or as a result of the expiration of the Term or any Renewal 
Term, this Section 7b and Sections 5, 7a, 8, 9, 10, 11, 12, 13, 14, 15, 161 
17 and 18 herein shall remain in full force and effect.

    8.   NON-COMPETE.

    As a material inducement for Company to enter into this Agreement, 
Employee agrees that for a period of 2 years following the termination of 
this Agreement for any reason whatsoever, Employee will not directly or 
indirectly (i) solicit, or agree to service for his benefit or the benefit of 
any third-party, any of Company's customers whether or not serviced directly 
by Employee during the term of this Agreement and (ii) disrupt, damage, 
impair or interfere with the business of Company, whether by way of breaching 
any obligation under this Agreement, interfering with any customer of 
Company, Company's employees, disrupting Company's relationships with 
customers, agents, representatives or vendors or otherwise.

    9.    REASONABLENESS.

    The parties recognize that this Agreement contains conditions, covenants, 
and time limitations that are reasonably required for the protection of the 
confidential information, trade secrets and


<PAGE>

business of the parties or a particular party.  If any limitation, covenant 
or condition shall be deemed to be unreasonable and unenforceable by a court 
or arbitrator of competent jurisdiction, then this Agreement shall thereupon 
be deemed to be amended to provide for modification of such limitation, 
covenant and/or condition to such extent as the court or arbitrator shall 
find to be reasonable and such modification shall not affect the remainder of 
this Agreement.

    10. REMEDIES.

    No remedy conferred by any of the specific provisions of this Agreement 
is intended to be exclusive of any other remedy given hereunder or hereafter 
existing at law or in equity.  The election of any one or more remedies by 
any party shall not constitute a waiver of the right to pursue other 
available remedies.

    11. SEVERABLE PROVISIONS.

    The provisions of this Agreement are severable, and if any one or more 
provisions may be determined to be judicially unenforceable, in whole or in 
part, the remaining provisions shall nevertheless be binding and enforceable.

    12. INJUNCTIVE RELIEF.

    Employee acknowledges that, in the event Employee breaches this 
Agreement, money damages will not be adequate to compensate Company for the 
loss occasioned by such breach.  Employee, therefore, consents, in the event 
of such a breach, to the granting of injunctive relief against Employee by 
any court of competent jurisdiction.

    13. BINDING AGREEMENT.

    The rights and obligations of the parties under this Agreement shall 
inure to the benefit of and shall be binding on their successors and assigns. 
Notwithstanding the foregoing, Employee may not assign his rights or 
obligations hereunder.

    14. NOTICES.

    Any notice to be given to the Company under the terms of this Agreement 
shall be addressed to the Company at the address of its principal place of 
business, and any notice to be given to Employee shall be addressed to him at 
his home address last shown on the records of the Company, or at such other 
address as either party may hereafter designate in writing to the other.  All 
notices shall be in writing and shall be delivered personally, sent by United 
States certified or registered mail, return receipt requested, first class 
postage prepaid, or by private messenger or courier service.  Any such notice 
shall be deemed to have been received on

<PAGE>

the earlier of (i) five (5) business days after it is mailed or (ii) the date 
it is actually received.

    15.  WAIVER.

    Either party's failure to enforce any provision or provisions of this 
Agreement shall not in any way be construed as a waiver of any such 
provision, or prevent that party thereafter from enforcing each and every 
other provision of this Agreement.

    16.  TITLE AND HEADINGS.

    Titles and headings to sections in this Agreement are for the purpose of 
reference only and shall in no way limit, define, or otherwise affect the 
provisions of it.

    17. ATTORNEYS' FEES AND COSTS OF LITIGATION.

    In any action at law or in equity to enforce any of the provisions or 
rights under this Agreement, the unsuccessful party, as determined by the 
court in a final judgment or decree, shall pay the successful party all 
costs, expenses and attorneys' fees actually incurred by the successful party 
(including, without limitation, the costs, expenses and attorneys fees on any 
appeal) and if the successful party shall recover a judgment in any such 
action or proceeding, the costs, expenses and attorneys, fees shall be 
included as part of the judgment.

    18.  GOVERNING LAW.

         The parties hereto agree that it is their intention and covenant that 
         this Agreement and performance under it, and all suits and 
         special proceedings that may ensue from its breach, be construed in 
         accordance with and under the laws of the State of California, and that
         in any action, special proceeding, or other proceeding that may be 
         brought arising out of, in connection with, or by reason of this 
         Agreement, the laws of the State of California shall be applicable and 
         shall govern to the exclusion of the law of any other forum, without 
         regard to the jurisdiction in which any action or special proceeding 
         may be instituted.

    19. WAIVER OF JURY TRIAL.

    Company and Employee hereby agree to waive their respective rights to a 
jury trial of any claim or cause of action raised upon or arising out of this 
Agreement.  The scope of this waiver is intended to be all encompassing of 
any and all disputes that may be filed in any court and that relate to the 
subject matter of this transaction, including without limitation, contract 
claims, tort claims, breach of duty claims, and all other common law and 
statutory claims. Company and Employee each acknowledge that this waiver is a 
material inducement for Company and Employee to enter into a business 
relationship, that Company and Employee have

<PAGE>

already relied on this waiver in entering into this Agreement and that each 
will continue to rely on this waiver in their related future dealings. 
Company and Employee further warrant and represent that each has reviewed 
this waiver with its legal counsel, and that each knowingly and voluntarily 
waives its jury trial rights following consultation with legal counsel. This 
waiver is irrevocable, meaning that it may not be modified either orally or 
in writing, and this waiver shall apply to any subsequent amendments, 
renewals, supplements or modifications to this Agreement.  In the event of 
litigation, this Agreement may be filed as a written consent to a trial by 
court.


 
         IN WITNESS WHEREOF, the parties hereto have executed this Agreement 
as of the day and year first above written.

    "COMPANY"                                           "EMPLOYEE"

    SPATIALIGHT, INC.,
    A NEW YORK CORPORATION

                                                    DEAN S. IRWIN
    By:
    NAME: WILLIAM E. HOLLIS
    TITLE: PRESIDENT & CEPO

<PAGE>

                                      EXHIBIT A
                                           



    2870. APPLICATION OF PROVISION PROVIDING THAT EMPLOYEE SHALL ASSIGN OR 
OFFER TO ASSIGN RIGHTS IN INVENTION TO EMPLOYER.

(a)  Any provision in an employment agreement which provides that an employee 
shall assign, or offer to assign, any of his or her rights in an invention to 
his or her employer shall not apply to an invention that the employee 
developed entirely on his or her own time without using the employer's 
equipment, supplies, facilities, or trade secret information except for those 
inventions that either:

    (1)  Relate at the time of conception or reduction to practice of the 
invention to the employer's business, or actual or demonstrably anticipated 
research or development of the employer.

    (2)  Result from any work performed by the employee for the employer.

(b)  To the extent a provision in an employment agreement purports to require 
an employee to assign an invention otherwise excluded from being required to 
be assigned under subdivision (a) the provision is against the public 
policy of this state and is unenforceable.


<PAGE>

                                                               EXHIBIT 10.16
                            MEADOWLARK OPTICS AND WAH-III
                                DISTRIBUTION AGREEMENT
                                           
      This agreement is made and entered into as of the twenty-first day of 
September, 1995, by and between WAH-III Technology Corp., having offices at 
16 Digital Drive, Suite 202, Novato, California 94949 (hereinafter referred 
to as "Manufacturer"), and Meadowlark Optics Inc., having its principal place 
of business at 7460 Weld County Road 1,  Longmont Colorado 80504 - 9470 
(hereinafter referred to as "Distributor").

In consideration of the mutual covenants and conditions herein contained, the 
parties mutually agree as follows:


1.   PREAMBLES:

          --    WAH-III (Manufacturer) and Meadowlark Optics 
                (Distributor) agree to enter into this Distribution 
                Agreement applying to Manufacturer's Display and Spatial 
                Light Modulator (SLM) technology.  As a component of this 
                agreement, both parties would like to establish a 
                distribution agreement from which we can utilize the 
                Distributors' established and future customer contacts as 
                well as their established sales and marketing 
                infrastructure to promote the product sales and increase 
                industry awareness of Manufacturer's technological 
                capabilities.

2.   PRODUCTS:

          --    AWH-III Display or SLM modules.
          --    Drive electronics, and applicable software, manuals and 
                accessories for driving Manufacturer's Display or SLM 
                modules, if applicable.
          --    A list of the products and their specifications is 
                provided in Exhibit 1A.

3.   TERRITORY:

                Manufacturer grants Distributor on a world wide 
                nonexclusive basis the rights and authorities to solicit 
                orders for the sale of Manufacturer's products pursuant 
                to Section 5 (Distribution Rights and Obligations).
                
4.   PRICING AND PAYMENT:

          --    Manufacturer will sell products to Distributor at prices 
                according to the current Manufacturers price list 
                provided in Exhibit 1B.
          --    Manufacturer will offer Distributor the same or lesser 
                pricing for quantity and product as any other distributor.
          --    Manufacturer reserves the right to change prices by 
                giving thirty (30) days written notice to Distributor.  
                All services provided by Distributor will be subject to 
                thirty (30) 

<PAGE>

                days written notice of change. It is understood that 
                Manufacturer relies on services provided by Distributor for 
                the fabrication of the products.
          --    Payment terms shall be net 50 days, payable in U.S. dollars 
                within fifty (50) days from the date of invoice or 3 days from 
                receipt of payment by Distributor's customer, whichever comes 
                first.  If Distributor secures pre-payment from customer, then 
                that percentage of payment shall be due Manufacturer within 
                three (3) days of that payment.
          --    Distributor will not be required to stock, or keep inventory 
                of Manufacturer's products.
          --    Manufacturers agrees not to undersell Distributor unless 
                Manufacturer had entered into an agreement, or commitment, 
                prior to this agreement. Distributor recognizes that  
                Manufacturer had a commitment prior to this agreement for 
                lower pricing.

5.   DISTRIBUTION RIGHTS AND OBLIGATIONS:

          --    Distributor agrees to pay all of its incurred expenses 
                associated with promoting and closing sales, i.e., sales 
                literature, advertisements, travel, lodging, 
                entertainment, etc.
          --    Distributor is obligated to put forth reasonable efforts 
                to promote and obtain sales of Manufacturer's products, 
                including data sheets to customers, calls, quotations, 
                trade shows, demonstrations on site and at customers' site.
          --    Distributor has the rights to distribute and represent 
                other like or similar products to those provided by 
                Manufacturer.
          --    All customer contacts that are initiated by Distributor 
                are deemed to be Distributor's exclusive customer and at 
                no time, without written consent of Distributor, will 
                Manufacturer circumvent that linkage either directly or 
                through other indirect means.
          --    Any disputes that arise with regard to multiple 
                distributors or distributor exclusivity will be 
                arbitrated by a mutally agreed upon third party.  Time is 
                of the esssence in resolving such disputes.

6.   DISCONTINUATION OF PRODUCT:

          --    Manufacturer shall have the right to discontinue the 
                availability of any product or to make design changes or 
                improvements at any time without incurring any obligation 
                to apply such changes or improvements to the products 
                previously purchased or in use in the Territory.
          --    Manufacturer will notify, in writing, Distributor with 
                three (3) days of any decision to discontinue, add, or 
                change a product offering. Any material stocked by 
                Distributor will receive full refund or upgrade by 
                Manufacturer at Manufacturer's expense.
          --    [Quotations will be valid for forty five (45) days.]  
                Obsolete products will be available for 45 days after 
                obsolescence. 

7.   PRODUCT DEVELOPMENT:

          --    All NRE charges or other costs associated with product 
                development work performed by Distributor for 
                Manufacturer, will be executed via purchase orders. The 
                terms and 

<PAGE>
                conditions that govern those purchase orders 
                will be negotiated on an individual basis, and further 
                they will be independent from this Agreement.

8.   PATENT INDEMNIFICATION:

          --    Manufacturer shall indemnify, and defend at Manufacturer's 
                expense, Distributor against any claims as they pertain to the 
                product, with the exception of any claims that pertain to the 
                process steps performed and provided by Distributor.
          --    Distributor shall indemnify, and defend at their expense, 
                Manufacturer against any claims that specifically relate 
                to Distributor's manufacturing processes performed to 
                yield the product.
                     --    Example, if WAH-III directs Meadowlark Optics to 
                           flatten and polish backplanes then WAH-III will 
                           indemnify and defend Meadowlark Optics against any 
                           infringements that deal with the broad scope of 
                           flattening or polishing a Display or SLM backplane. 
                           However, the specific processes or procedures 
                           utilized by Meadowlark Optics to flatten or polish 
                           the backplanes is their liability and they must hold 
                           harmless and defend WAH-III against any claims made 
                           with respect to those procedures.
          --    Manufacturer provides no representations or indemnification 
                covering product applications.
          --    In the event that any product or any part thereof is held 
                to constitute infringement, the Manufacturer shall, at 
                its own expense and discretion, either procure for the 
                Distributor or subsequent purchaser the right to continue 
                using said product, or part, or replace the same with a 
                non-infringing product, or part, or modify it so that it 
                becomes non-infringing, or refund the purchase price, 
                less depreciation thereof.

9.   PRODUCT WARRANTIES:

          --    Manufacturer warrants that the goods sold to Distributor 
                hereunder are free from defects of material and 
                workmanship for ninety (90) days from date of sale to the 
                ultimate consumer by Distributor except for products or 
                component warranties that have been clearly identified to 
                have a shorter warranty period.
          --    Manufacturer will repair or replace defective products at 
                Manufacturer's discretion within twelve (12) months from 
                date of purchase at Distributors discretion.
          --    Distributor warrants all products and services integrated 
                into Manufacturer's products for ninety (90) days from 
                manufacture, and repair or replace products and service 
                at Manufacturers discretion within twelve (12) months 
                from date of manufacture.
                
10.  TERM AND TERMINATION:

          --    This Agreement shall expire three (3) years from the date 
                of execution.

<PAGE>

          --    This agreement may be terminated in the event Distributor 
                becomes insolvent or files an application in bankruptcy, 
                or if Distributor makes a general assignment for the 
                benefit of creditors.
          --    This Agreement may be terminated in the event 
                Manufacturer becomes insolvent or files an application in 
                bankruptcy, or if Manufacturer makes a general assignment 
                for the benefit of creditors.
          --    This Agreement may be terminated immediately by the 
                non-defaulting party, if such party is not itself in 
                default of the Agreement, if the other party breaches any 
                covenant or warranty made by it in this Agreement and if, 
                after ten (10) days written notice to cure any such 
                default, the default is not cured.
          --    In the event that the controlling ownership of either the 
                Manufacturer or the Distributor changes, then either 
                party to this Agreement may terminate this Agreement, 
                upon giving the other party at least forty-five (45) days 
                prior written notice of such termination.
          --    This agreement may be terminated by either party for any 
                reason or no reason with with 90 day written notification

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be 
executed on the day and year first above written.


DISTRIBUTOR                            MANUFACTURER




- ----------------------------           -----------------------------
Anthony Artigliere                    Dean Irwin
Sales & Marketing                      WAH-III Technology

SIGNED 9-22-95                         SIGNED 10-13-95
- ----------------------------           -----------------------------
Date                                   Date


<PAGE>

                                                               EXHIBIT 10.17
                                EMPLOYMENT AGREEMENT 

    This Employment Agreement is made and entered into by and between
Spatialight, Inc. (the "Company") and L. John Loomis ("Loomis") as of February
17, 1997 (the "Effective Date").

    1.        POSITION AND DUTIES:   

         1.1  Effective February 17, 1997 (the "Commencement Date"), Loomis
will be employed by the Company as its Senior Executive Vice President and Chief
Operating Officer ("COO") reporting to William E. Hollis, President and Chief
Executive Officer.  It is expected that at the next regularly scheduled meeting
of the Company's Board of Directors (the "Board") Hollis will be appointed
Chairman of the Board.  If this occurs, the Company will recommend that the
Board approve Loomis for employment as the Company's President and COO, and will
further recommend Loomis for a seat on the Company's Board.

         1.2  Loomis agrees to devote his full business time, energy and skill
to his duties at the Company.  These duties shall include, but not be limited
to, assisting in all efforts to raise equity financing, assisting with
presentations to shareholders and the Board, providing technical marketing
expertise to the Company, assisting in the development of the Company's business
plan and any other duties consistent with Loomis' position(s), as well as any
other duties that may be assigned to Loomis from time to time by the Board. 

         1.3  Loomis further agrees to undertake his best efforts to induce
Paul Beard, to accept employment with the Company.

    2.        COMPENSATION:   

         2.1  BASE SALARY:  Loomis will be paid an annual salary of $175,000,
less applicable withholding, in accordance with the Company's normal payroll
procedures.  Loomis' salary will be reviewed by the Board on an approximately
annual basis, and may be subject to adjustment based upon various factors
including, but not limited to, Loomis' performance and the Company's
profitability.

         2.2  PERFORMANCE BONUS PLAN:  Loomis will be eligible to participate 
in the Company's performance bonus plan (the "Bonus Plan"), which currently 
provides for a bonus of twenty (20) percent of salary upon achievement of 
pre-established goals.  Under the Bonus Plan, all bonuses, if earned, are 
paid at the end of the fiscal year.  Any bonus will be governed by the terms 
of the Company's standard Bonus Plan in effect at the time.

         2.3  EQUITY STAKE:  The Company will recommend that its Board 
approve the issuance to Loomis of options to purchase 400,000 shares of the 
Company's common stock (the


                                       1
<PAGE>

"Option") in accordance with the Company's Stock Option Plan (the "Plan").  
The Plan provides that fifty percent of options vest upon the completion of 
one year's service and the remaining fifty percent of options vest upon the 
completion of the second year's service.  However, in the event that the 
Company files for bankruptcy protection pursuant to the United States 
Bankruptcy Code, the parties agree that all of the options issued pursuant to 
the Option shall become fully vested as of the date the Company files its 
Petition for Bankruptcy Protection.  Except as otherwise provided herein, the 
Option shall be subject to the terms and conditions of the Company's stock 
option plan and the Company's standard form of stock option agreement, which 
Loomis shall be required to sign as a condition of the issuance of the 
Initial Stock Option.

         2.4  SIGNING BONUS:  Immediately upon execution of this Agreement, 
the Company shall provide Loomis with a signing bonus in the amount of 
Twenty-Five Thousand Dollars ($25,000.00)(the "Signing Bonus").  The Signing 
Bonus is not payment for any labor performed by Loomis and consequently does 
not constitute "wages" under the California Labor Code.  In the event that 
Loomis voluntarily terminates his employment with the Company prior to the 
expiration of twelve months following the Commencement Date, Loomis shall 
reimburse the Company for the Signing Bonus.

         2.5  BENEFITS:  Loomis will be entitled to participate in all of the 
Company's benefit plans, as those plans may change from time to time, on the 
same terms as all other employees of the Company.

    3.        TERM OF EMPLOYMENT:  Loomis' employment with the Company 
pursuant to this Agreement is for a three-year period, commencing on the 
Commencement Date, subject to the provisions regarding termination set forth 
below (the "Term").  If neither party gives the other written notice of 
termination or a desire to change the provisions herein, on or before the 
thirtieth (30th) day prior to the expiration of the Term, this Agreement 
shall be automatically renewed for an additional one (1) year period (the 
"Renewal Term").  Thereafter, if neither party gives the other written notice 
of termination or a desire to change the provisions herein, on or before the 
thirtieth (30th) day prior to the expiration of each Renewal Term, this 
Agreement shall be renewed for an additional one (1) year period.

    4.        BENEFITS UPON TERMINATION:  

    Notwithstanding paragraph 3 above, Loomis' employment may be terminated 
by Loomis or the Company at any time, with or without notice and with or 
without cause.  In the event that either party elects to terminate this 
Agreement prior to the expiration of the contract term, benefits shall be 
provided as set forth below.  

         4.1  VOLUNTARY TERMINATION:  In the event that Loomis voluntarily 
resign from his employment with the Company, or in the event that Loomis' 
employment terminates as a result of his death or disability, Loomis shall be 
entitled to no compensation or benefits from the Company other than those 
earned under paragraph 2 above through the date of his termination.


                                       2
<PAGE>

         4.2  INVOLUNTARY TERMINATION:  In the event of the termination of 
Loomis' employment by the Company for the reasons set forth below, Loomis 
shall be entitled to the following:

                   TERMINATION FOR CAUSE:  If Loomis' employment is 
terminated by the Company for cause as defined below, Loomis shall be 
entitled to no compensation or benefits from the Company other than those 
earned under paragraph 2 through the date of Loomis' termination.

              For purposes of this Agreement, a termination "for cause" 
occurs if Loomis are terminated for any of the following reasons:

                   (1)       theft, dishonesty, or falsification of any
employment or Company records;

                   (2)       conviction of a felony or any act involving moral
turpitude;

                   (3)       consistent poor performance, as determined by the
Board in its sole discretion; 

                   (4)       improper disclosure of the Company's confidential
or proprietary information;

                   (5)       any intentional act by Loomis that has a material
detrimental effect on the Company's reputation or business; or

                   (6)       any material breach of this Agreement, which
breach, if curable, is not cured within thirty (30) days following written
notice of such breach from the Company.

              b.        TERMINATION FOR OTHER THAN CAUSE:  If Loomis' 
employment is terminated by the Company for any reason other than cause, 
Loomis shall be entitled to continuation of Loomis' salary and all other 
benefits, including, but not limited to, vesting in all stock options, for 
six months following the termination of Loomis' employment. 

    5.        CONFIDENTIAL AND PROPRIETARY INFORMATION:  As a condition of 
Loomis' employment with the Company, Loomis will be required to sign the 
Company's standard form of proprietary information and assignment of 
inventions agreement.  As a further condition of Loomis' employment, Loomis 
will be required to cause the assignment of all patents issued in relation to 
the wireless technology for the home environment (the "Patents") to the 
Company.

    6.        ATTORNEYS' FEES:   The prevailing party shall be entitled to 
recover from the losing party its attorneys' fees and costs incurred in any 
action brought to enforce any right arising out of this Agreement.


                                       3
<PAGE>

    7.        INTERPRETATION:   This Agreement shall be interpreted in 
accordance with and governed by the laws of the State of California.

         ASSIGNMENT:   In view of the personal nature of the services to be 
performed under this Agreement by Loomis, Loomis shall not have the right to 
assign or transfer any of his obligations under this Agreement.

    9.        ENTIRE AGREEMENT:   This Agreement, along with any agreements 
referred to in paragraph 2, relating to stock options and paragraph 5, 
relating to proprietary information and assignment of inventions, sets forth 
the entire agreement between Loomis and the Company regarding the terms and 
conditions of Loomis' employment, and supersedes all prior negotiations, 
representations or agreements between Loomis and the Company regarding 
Loomis' employment, whether written or oral.

    10.       NO REPRESENTATIONS:  Loomis acknowledges that his is not 
relying, and have not relied, on any promise, representation or statement 
made by or on behalf of the Company that is not set forth in this Agreement.  

    11.       MODIFICATION:   This Agreement may only be modified or amended 
by a supplemental written agreement signed by Loomis and an authorized member 
of the Board.

    IN WITNESS WHEREOF, the parties have executed this Agreement as of the 
date and year written below.


                                  SPATIALIGHT, INC.



Date:                             By:                            
     ---------------------           ----------------------------


                                  Its:                           
                                      ---------------------------



Date:                                                              
     ---------------------        -------------------------------
                                  L. John Loomis

                                       4

<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           1,324
<SECURITIES>                                         0
<RECEIVABLES>                                       40
<ALLOWANCES>                                         0
<INVENTORY>                                         75
<CURRENT-ASSETS>                                 1,452
<PP&E>                                             157
<DEPRECIATION>                                      88
<TOTAL-ASSETS>                                   1,533
<CURRENT-LIABILITIES>                              203
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         8,794
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                     1,533
<SALES>                                            176
<TOTAL-REVENUES>                                   176
<CGS>                                              141
<TOTAL-COSTS>                                    1,029
<OTHER-EXPENSES>                                   183
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (1,177)
<INCOME-TAX>                                         2
<INCOME-CONTINUING>                            (1,179)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,179)
<EPS-PRIMARY>                                    (.16)
<EPS-DILUTED>                                    (.16)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission